LBPEA01 HIV-1 pol gene diversity and molecular dating of HIV-1 C from Sri LankaE-posterA1
LBPEA02 Identification and characterization of a CXCR4-tropic transmitted/founder HIV-1 in an acute CRF01_AE infectionE-posterA3
LBPEA03 Impact of alcohol on HIV infection in hepatocytesE-posterA4
LBPEA04 Plasma and antibody glycomic biomarkers predict time to HIV rebound and viral setpointE-posterA22
LBPEA05 Detection of inducible replication competent proviruses in adolescents following early initiation and 14 years of viral suppression in BotswanaE-posterA22
LBPEA06 CD57 expressing mature NK cells negatively correlate with the level of intact and hypermutated pro-viral DNA in HIV-1 infected ART-suppressed subjectsE-posterA24
LBPEA07 Estradiol inhibits HIV-1BaL infection and induces expression of CFL1 and LSP1 in endocervical mucosa and in peripheral blood mononuclear cellsE-posterA30
LBPEA08 Efficacy of on-demand PrEP or PEP with single oral doses of combination tenofovir alafenamide, emtricitabine, elvitegravir, and cobicistat (TAF/FTC/EVG/c) in macaquesE-posterA35
LBPEA09 Viral and immune dynamics in orally SHIV-infected ART-treated infant rhesus macaquesE-posterA52
LBPEA10 Treatment with the IL-15 superagonist N-803 accelerates time-to-viremia in a novel in vivo humanized mouse model developed for rapid preclinical evaluation of latency reversing agent efficacyE-posterA52
LBPEB11 Development and validation of a point-of-care, urine assay to measure adherence to PrEP and ARTE-posterB11
LBPEB12 Similar 12 & 24 month preliminary outcomes for TRU/DTG and TDF/FTC/EFV regimens in Botswana: The Botswana Epidemiological ART Treatment Cohort Study (The BEAT)E-posterB38
LBPEB13 Safety and antiviral activity over 10 days following a single dose of subcutaneous GS-6207, a first-in-class, long-acting HIV capsid inhibitor in people living with HIVE-posterB45
LBPEB14 Weight gain during pregnancy among women initiating dolutegravir in BotswanaE-posterB58
LBPEB15 Low dose efavirenz (Efavirenz 400mg) combined with tenofovir 300mg and lamivudine 300mg shows excellent viral suppression among HIV pregnant women receiving routine HIV care in ZambiaE-posterB58
LBPEB16 Risk of sexually transmitted infections among women randomized to DMPA-IM, the copper IUD, and levonorgestrel implant in the Evidence for Contraceptive Options and HIV Outcomes (ECHO) trialE-posterB60
LBPEB17 Early relative effects of intramuscular depot medroxyprogesterone acetate, a copper intrauterine device and the levonorgestrel implant on HIV disease progression: results from the ECHO TrialE-posterB60
LBPEB18 Pharmacokinetics (PK) and safety of zidovudine (ZDV), lamivudine (3TC) and lopinavir/ritonavir (LPV/r) in HIV-infected children with severe acute malnutrition (SAM) in sub-Saharan Africa: IMPAACT Protocol P1092E-posterB64
LBPEB19 Emergence of clonal invasive nontypeable Haemophilus influenzae in HIV-positive Black men who have sex with men in Metropolitan Atlanta, 2017-2018E-posterB76
LBPEC20 HIV epidemics to the rise and concentrating in young men in Latin AmericaE-posterC1
LBPEC21 Multi-country evaluation of survival and HIV-free survival among children under 3 years of age of women living with HIV in eight sub-Saharan African countries: Results from population-based HIV impact assessmentsE-posterC2
LBPEC22 Persistently high HIV incidence among trans women, San FranciscoE-posterC4
LBPEC23 High HIV incidence among young women in South Africa: data from the ECHO trialE-posterC7
LBPEC24 Modelling progestin-based contraceptive use in high DMPA use and high HIV incidence settingsE-posterC14
LBPEC25 Integrating oral PrEP delivery into a large HIV endpoint-driven clinical trial in Eastern and Southern Africa: the ECHO trial experienceE-posterC27
LBPEC26 Virologic assessment of seroconverters in a phase III dapivirine vaginal ring trialE-posterC28
LBPEC27 High self-reporting of HIV self-test results through an interactive voice response telephone line in inner city JohannesburgE-posterC33
LBPEC28 “It's fast and convenient”: HIVST is highly acceptable to people who inject drugs and their intimate partners in rural and urban settings in VietnamE-posterC33
LBPEC29 Performance of syndromic screening for bacterial STIs among men who have sex with men (MSM) in Dar es Salaam, TanzaniaE-posterC35
LBPEC30 In utero mother-to-child transmission (MTCT) in Botswana does not differ between efavirenz/tenofovir/emtricitabine (EFV/TDF/FTC) and dolutegravir/tenofovir/emtricitabine (DTG/TDF/FTC)E-posterC37
LBPEC31 Results from an impact evaluation of a school-based sexuality and HIV revention education activity in South AfricaE-posterC54
LBPED32 Effective public-private partnerships for sustainable antiretroviral therapy: Outcomes of the Right to Care Health Services GP down-referral programE-posterD2
LBPED33 State licensure laws' relationship to PrEP prescribing by nurse practitioners and physician assistants in the United States, 2017E-posterD3
LBPED34 Oral self-testing for individuals absent or refusing testing during home-based HIV testing - a cluster-randomized trial in Lesotho (HOSENG trial)E-posterD12
LBPED35 Temporal relationship between heavy drinking, drug use and antiretroviral medication nonadherenceE-posterD14
LBPED36 Twelve-month retention and viral load outcomes from a non-inferiority cluster randomized trial extending adherence club ART refill dispensing intervals to 6- monthlyE-posterD15
LBPED37 HIV self-testing acceptability, feasibility and motivations among young people in South Africa: A demonstration community-based studyE-posterD30
LBPED38 Strengthening capacity toward the sustainable transition of HIV and TB services to Kenya prisons serviceE-posterD42
LBPED39 Prioritizing continuity of HIV services in Mozambique post cyclone IdaiE-posterD45
LBPED40 Gaps in the PrEP continuum of care in a large cohort of insured transgender patientsE-posterD46
LBPED41 Longitudinal cascades more accurately assess health systems performance than cross-sectional cascades such as UNAIDS 90-90-90 targets: A simulation-based demonstrationE-posterD49
LBPED42 Randomized controlled trial of a positive affect intervention to reduce HIV viral load among methamphetamine-using sexual minority menE-posterD64
LBPED43 The impact of memory and substance use on HIV clinic visitsE-posterD67
LBPED44 Mortality after receipt of short-term incentives for HIV care among adults initiating ART in Tanzania: Follow-up of a randomized trialE-posterD106
LBPED45 Is having healthcare coverage enough to increase viral suppression among men who have sex with men in the United States?: Results from HPTN 078E-posterD112
LBPED46 Tolerability, safety and efficacy of MK-8591 at doses of 0.25 to 2.25 mg QD, in combination with doravirine and lamivudine through 24 weeks in treatment-naïve adults with HIV-1 infectionE-posterB38
MOPEA007 Dysfunctional natural killer cell subsets correlate with disease progression in HIV-infected Kenyan childrenE-posterA6
MOPEA008 HIV-infected, ART-suppressed intravenous opioid users receiving naltrexone have lower immune activation compared to similar patients receiving methadoneE-posterA6
MOPEA009 Reduced immune activation and low inflammatory monocyte frequencies during pregnancy are associated with preterm deliveryE-posterA6
MOPEA010 HLA-F on autologous HIV-infected cells activates primary natural killer (NK) cells expressing the activating killer immunoglobulin-like receptor (KIR) 3DS1E-posterA6
MOPEA011 Toll-like Interleukin-1 Receptor Regulator (TILRR) is a risk factor in vaginal HIV-1 infection through mediating inflammatory response and potentiating the leukocytes chemotaxisE-posterA6
MOPEA012 Antibody-bound HIV-1 viruses transmigrate through tissue barriersE-posterA7
MOPEA013 CD3+CD8low T cells harbored dysfunctional functions in patients at the earliest stage of HIV infectionE-posterA8
MOPEA014 Comparative study of subpopulations of B lymphocytes of blood and lymph nodes in the different stages of HIV infectionE-posterA8
MOPEA015 The expression of immunoregulatory molecules in HIV-specific cells is associated with the activation of CD8 T cellsE-posterA8
MOPEA016 CD4+ T cells expressing negative checkpoint receptors are associated with decreased mitochondrial oxidative phosphorylation in chronic HIVE-posterA8
MOPEA017 Nef genotype influences immune control in HIV-1 infected individuals carrying protective allelesE-posterA8
MOPEA018 Phenotype and functionality of CD8+ T cells before and after cART are related to the viral reservoir size in HIV-infected subjectsE-posterA8
MOPEA019 HIV reservoir size is related to CD4+ and CD8+ T cell differentiation in HCV/HIV-coinfected individuals treated with direct acting antivirals (DAAs)E-posterA8
MOPEA020 Women exposed to recent sexual violence show increased inflammatory and decreased anti-HIV biomarkers in the reproductive tractE-posterA9
MOPEA022 Methamphetamine Use is associated with increased T cell immune exhaustion in ART treated HIV infected adultsE-posterA10
MOPEA023 Extracellular vesicle-associated cytokines in HIV-infected human ex vivo tonsilsE-posterA10
MOPEA024 Primed immature neutrophils in primary and chronic SIV infection, a new player in systemic inflammationE-posterA10
MOPEA026 Persistence of “defective” HIV-1 proviruses and markers of immune activation and inflammation in HIV-infected individuals on suppressive combination antiretroviral therapy (cART)E-posterA10
MOPEA027 Increased expression of TRAIL receptor DR5 in monocytes and its relationship with serum levels of IL-18 from HIV+ ART naïve patientsE-posterA11
MOPEA028 Immune activation is associated with poor CD4 reconstitution - A study from South IndiaE-posterA11
MOPEA030 Extracellular vesicles and their microRNA contents are biomarkers of HIV-1 disease progressionE-posterA13
MOPEA031 Persistent elevation of Tim-3 and PD-1 on memory T cells despite early ART initiation during primary HIV infectionE-posterA13
MOPEA032 HIV DNA levels, IL28B genotype and CCR5Δ32 among different groups of HIV patientsE-posterA13
MOPEA033 Serum bone-derived extracellular vesicles are associated with bone loss during antiretroviral therapy in HIV+ individualsE-posterA14
MOPEA036 Bystander cell death by pyroptosis of astrocytes requires cell-to-cell transmission of HIVE-posterA16
MOPEA037 Plasma brain-derived extracellular vesicles are associated with monocyte activation in individuals with HIV-related cognitive impairmentE-posterA16
MOPEA038 Production of chemokine fractalkine in HIV brain inflammation: A new approach to understand and treat HIV neuro-pathogenesisE-posterA17
MOPEA039 Modeling the cross-talk between HIV-infected microglia and neuronsE-posterA17
MOPEA073 Immune-phenotypic characteristics associated with an effective acute-phase response predict a reduced amount of integrated HIV DNA in naïve CD4+ T cells in patients treated during acute HIV infectionE-posterA34
MOPEA079 Vaccine-induced Vif-specific CD8+ T cells exert strong suppressive pressure on acute SIV replication post-infectionE-posterA38
MOPEA080 Novel gp41 W614A-3S peptide-CRM conjugated vaccine formulated in MF59-like squalene emulsion promotes broadly neutralizing antibodies against HIV-1E-posterA40
MOPEA081 Inflammasome SNPs are associated with risk/protection for tuberculosis and TB-AIDS-immune reconstitution inflammatory syndrome (IRIS) outcomesE-posterA44
MOPEA082 Role of active case finding of TB, HIV and HIV TB co-infection case notification amongst infants and children in high risk groups in ZimbabweE-posterA44
MOPEA083 HIV reservoir size is not affected neither by HCV coinfection nor by DAAs therapyE-posterA45
MOPEA084 Establishment of anti-hepatitis C virus IgG avidity test for dried serum/plasma spotsE-posterA45
MOPEA085 HIV infection of hepatitis B virus (HBV)-infected hepatocytes increases CXCL10 production and is associated with liver fibrosis in HIV-HBV co-infected individualsE-posterA45
MOPEA086 Immune activation markers associated with levels and diversity of intact HIV proviruses during HIV-HBV co-infectionE-posterA45
MOPEA087 Low-level detection of HIV DNA in the liver in HIV-HBV coinfected individuals on HBV-active ARTE-posterA45
MOPEA088 Long-term modification of the HIV reservoir after HCV clearance with direct-acting antivirals (DAAs): The potential role of RibavirinE-posterA45
MOPEA089 Implication and detection of hepatitis B virus immune escape mutants among HIV-infected population group In Southwestern NigeriaE-posterA45
MOPEA090 HTLV-1 and HIV-2 co-infections in Cabo VerdeE-posterA47
MOPEA091 Immunosenescence, thymic output deficiency and mobilization profile of T cell Vβ repertoire are related to relapses of visceral leishmaniasis in HIV-coinfected patientsE-posterA47
MOPEA092 HIV-1 infection in astrocytes raises intracellular ROS improving Trypanosoma cruzi multiplicationE-posterA47
MOPEA093 Malnutrition reduces production of IFN-γ among HIV-infected adults initiating ART in UgandaE-posterA48
MOPEA094 Evaluating mechanisms of antiretroviral-mediated cardiovascular risk associated with platelet activationE-posterA48
MOPEA095 Circulating mitochondrial DNA is higher in acute than in chronic HIV infection and correlates with plasma levels of LPS-binding protein but not of 16S rRNA bacterial DNAE-posterA49
MOPEB112 Baseline CD4 count as indicator of success of Test and Treat campaign: Data from the Thai Red Cross Anonymous Clinic, Bangkok, ThailandE-posterB1
MOPEB113 Rapid virological suppression at Primary HIV is not associated with long term immune recovery: Results from the HEATHER cohortE-posterB1
MOPEB114 Mortality of HIV infection by age, period, disease stage, care cascade and antiretroviral therapy statusE-posterB4
MOPEB115 Determinants of sub-optimal immune response after antiretroviral therapy initiation in HIV-1 infectionE-posterB5
MOPEB116 Delay in the attention of virological failure and its impact on mortality in a country with high levels of pretreatment HIV drug resistanceE-posterB5
MOPEB117 What motivates or prevents frequent HIV testing among young men who have sex with men in New York City?E-posterB7
MOPEB118 Viral load assay performs comparably to early infant diagnosis assay to diagnose infants with HIVE-posterB7
MOPEB119 “Treat and Test”: Engaging PLHIV for accelerated case detectionE-posterB7
MOPEB120 Performance, usability and Acceptance of the blood-based INSTI HIV self test in high and low HIV prevalence populations in sub-Saharan AfricaE-posterB7
MOPEB121 Verification of cobas® c6800/8800 HIV 1/2 qualitative NAT assay for use in South Africa public sector and a new indeterminate range setE-posterB7
MOPEB122 Implementing an indeterminate range for more accurate early infant diagnosis: 2018 WHO recommendationsE-posterB7
MOPEB123 Efficiency of risk assessment tool among Orphans and Vulnerable children to targeted HIV testing services: A case study of Calabar, NigeriaE-posterB7
MOPEB124 Field evaluation of Alere HIV Combo to identify acute HIV infection in Lusaka, ZambiaE-posterB7
MOPEB125 Molecular epidemiology of clinical HIV-1 sequences isolated between 2008-2018 in CubaE-posterB8
MOPEB126 Is it time to change the WHO definition of virologic suppression in the era of HIV epidemic control? 12-month virologic outcomes in patients with WHO defined virologic suppression in KenyaE-posterB10
MOPEB127 High prevalence of virologic failure among pregnant and breastfeeding women in HIV care in Kinshasa: First findings in a continuous quality improvement intervention trialE-posterB10
MOPEB128 Quantification of HIV1-RNA viral load using automated filtered dried plasma spot, a head-to-head comparison studyE-posterB10
MOPEB129 HIV viral load suppression among adult patients by time to ART initiation during a pilot of “Test and Start” — Nigeria, 2015-2016E-posterB10
MOPEB130 Incidence of viremia events (≥50 copies/ml) among HIV patients with documented viral suppression (< 50 copies/ml) after ART initiation in Ndhiwa, KenyaE-posterB10
MOPEB131 Time to switch to second-line antiretroviral therapy among HIV positive people with unsuppressed viral load in Mutare District, ZimbabweE-posterB10
MOPEB133 A meta-analysis of using dried blood spots for HIV viral load testing with lower treatment failure thresholdsE-posterB10
MOPEB134 Incentives conditioned on tenofovir levels to increase adherence among young women on PrEP in Cape TownE-posterB11
MOPEB135 A method to quantify dapivirine in small hair samples as a metric of adherence and exposure to the dapivirine vaginal ringE-posterB11
MOPEB136 Emerging resistance to integrase inhibitors by next generation sequencingE-posterB12
MOPEB137 HIV-1 resistance testing at second-line: Avoiding unnecessary switch to third-lineE-posterB12
MOPEB139 Development and evaluation of a low-cost drug resistance test “OLA-Simple” for non-nucleoside-based ART for Mexico's HIV populationE-posterB12
MOPEB140 High prevalence of drug-resistant HIV-1 among infants newly diagnosed with HIV-1 in MalawiE-posterB12
MOPEB141 Validation of PANDAA qDx HIVDR RTI, a simple and scalable real-time PCR-based HIV drug resistance genotyping kit for the management of NNRTI-based ART failureE-posterB12
MOPEB148 HIV viral load dynamics and impact on mortality in El Salvador, 2015-2017E-posterB14
MOPEB149 Progressive linear antibodies quantitation decay over time among indiviudals under antiretroviral suppressive treatment; results of SPARC-7 clinical trialE-posterB14
MOPEB223 Mortality trends among early ART initiators following implementation of test and start approach at 11 high volume HIV clinics, TASO UgandaE-posterB37
MOPEB224 TDF-based regimens: Are they suitable for same-day antiretroviral treatment initiation without baseline laboratory test results in Thailand?E-posterB38
MOPEB225 Week 96 resistance and adherence analyses of the once-daily, single-tablet regimen (STR) darunavir/cobicistat/emtricitabine/tenofovir alafenamide (D/C/F/TAF) in the AMBER and EMERALD phase III trialsE-posterB38
MOPEB226 Characterization of HIV-1 gag polymorphisms in Ugandan patients failing second line ARTE-posterB38
MOPEB227 Options for clinically diagnosing cART neurotoxicity in HIV-positive patientsE-posterB38
MOPEB228 Validation of HIV-ASSIST, an online clinical decision support tool to guide patient-centered ARV regimen selectionE-posterB38
MOPEB229 Cost-effectiveness of Dolutegravir in HIV-1 treatment-naïve patients in MexicoE-posterB38
MOPEB230 Predictors of death in a large cohort of HIV patients in UkraineE-posterB38
MOPEB231 Dolutegravir (DTG) plus lamivudine (3TC) versus DTG plus tenofovir/emtricitabine (TDF/FTC) fixed-dose combination in the GEMINI studies - viral load rebound including 'blips' through 48 weeksE-posterB38
MOPEB232 Adoption of 2018 WHO recommendations on preferred first line antiretroviral therapyE-posterB38
MOPEB233 Comparing low-dose efavirenz to standard-dose efavirenz and dolutegravir: A systematic literature review and network meta-analysisE-posterB38
MOPEB234 A subgroup analysis of the week 96 efficacy and safety results evaluating fostemsavir in heavily treatment-experienced HIV-1 infected participants in the phase 3 BRIGHTE study: Results from the randomized cohortE-posterB39
MOPEB235 Long-term outcomes in a large randomized trial of HIV Salvage therapy: 96-week final results of AIDS clinical trials group study A5241 (OPTIONS)E-posterB39
MOPEB236 Identifying heavily treatment-experienced patients in a large administrative claims databaseE-posterB39
MOPEB237 Impact of archived M184V/I mutations on the effectiveness of switching to coformulated elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide among virologically suppressed HIV-positive patientsE-posterB41
MOPEB238 A Phase 3b, multicenter, open-label study switching from an Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide(E/C/F/TAF) or a Tenofovir disoproxil fumarate containing regimen to Bictegravir/Emtricitabine/Tenofovir Alafenamide (B/F/TAF) in virologically-suppressed, HIV-1 infected subjects aged ≥65 yearsE-posterB41
MOPEB239 Discontinuation of long-term dolutegravir treatment is associated with UGT1A1 gene polymorphismsE-posterB42
MOPEB240 Prevalence and nature of potential drug-drug interactions among hospitalized HIV patients with suspected meningitis in UgandaE-posterB43
MOPEB241 Keeping the pressure on archived NRTI resistance: Switching to bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF) triple therapy in study 4030E-posterB44
MOPEB242 Low-frequency resistance variants in ART-naïve participants do not affect bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF) triple therapy treatment outcomeE-posterB44
MOPEB243 Previously undocumented preexisting resistance and maintenance of virologic suppression in HIV-1 RNA-suppressed patients switching to Bictegravir/Emtricitabine/Tenofovir Alafenamide (B/F/TAF)E-posterB44
MOPEB244 Impact of patient characteristics on integrase resistanceE-posterB44
MOPEB245 Pre-treatment and acquired HIV drug resistance in Vietnam: Results from a nationally representative surveyE-posterB44
MOPEB246 Prevalence of heavily treatment-experienced persons with HIV in the United States, 2000-2017E-posterB44
MOPEB247 Impaired genotypic resistance interpretation due to HIV-1 variant specific markersE-posterB44
MOPEB248 National survey of pre-treatment HIV drug resistance in Cuban patientsE-posterB44
MOPEB249 Differential detection of M184V/I between plasma historical HIV genotypes and proviral DNA from PBMCsE-posterB44
MOPEB250 High level of HIV-1 drug resistance among first-line failures in three health facilities in Tete province and Maputo city, MozambiqueE-posterB44
MOPEB251 Analysis of HIV type 1 subtypes C p6gag sequences for PTAP motif duplication and PYXE insertionE-posterB44
MOPEB252 Primary resistance to integrase inhibitors among recombinants in Kinshasa using DBSE-posterB44
MOPEB255 High level of pre-treatment HIV-1 drug resistance in a rural and an urban settings in MozambiqueE-posterB44
MOPEB256 Interest in and preferences for multipurpose technology for combined contraception and antiretroviral therapy and non-oral antiretroviral therapy among women living with HIV in western KenyaE-posterB45
MOPEB257 Monthly long-acting cabotegravir and rilpivirine is non-inferior to oral ART as maintenance therapy for HIV-1 infection: Week 48 pooled analysis from the Phase 3 ATLAS and FLAIR studiesE-posterB45
MOPEB258 Patient reported outcomes on long-acting Cabotegravir + Rilpivirine as maintenance therapy: FLAIR 48 week resultsE-posterB45
MOPEB259 Characteristics and health service utilization of key populations living with HIV in Nigeria recruited through facility-based services versus outreach servicesE-posterB46
MOPEB260 Real-time antiretroviral electronic adherence monitoring in young African American MSM: Information for intervention developmentE-posterB46
MOPEB261 Do clinic transfers lead to gaps in clinical care? Evidence from a large cohort of HIV-infected adults in South AfricaE-posterB46
MOPEB262 High rates of viral load suppression among patients participating in a home-based, nurse-led ART adherence support intervention in Kazakhstan, Kyrgyzstan and TajikistanE-posterB47
MOPEB263 A pilot test of biometric fingerprint scanning to monitor engagement in HIV care for women in Option B+E-posterB47
MOPEB264 Assessing the facilitators and barriers of antiretroviral therapy adherence among key populations (KP) in Mumbai, India: A way forward for designing KP-centric adherence interventionsE-posterB47
MOPEB265 Long-term virologic responses to antiretroviral therapy among patients entering adherence clubs in Khayelitsha, Cape Town, South AfricaE-posterB47
MOPEB266 Antiretroviral therapy adherence and viral suppression in HIV-infected population; A case study of Coast General Hospital, Mombasa County-KenyaE-posterB47
MOPEB267 Is DTG+3TC and DTG+RPV effective and safe in clinical practice? Evidence from real world dataE-posterB49
MOPEB268 Seminal HIV-1 RNA and drug concentrations in DTG+3TC dual therapy (ANRS167 LAMIDOL)E-posterB49
MOPEB269 A switch to dolutegravir in combination with boosted darunavir is safe and effective in suppressed patients with HIV - a subanalysis of the dualis studyE-posterB49
MOPEB270 Improved case detection and management of advanced HIV disease through TB contact risk stratification and implementation of a package of interventions in a rural district of MozambiqueE-posterB49
MOPEB271 Engagement in care and viral suppression 2 years after home-based same-day ART initiation in Lesotho: 24-months outcomes of CASCADE trialE-posterB49
MOPEB272 The impact of vorinostat and AGS-004, a dendritic cell-based immunotherapy, on persistent HIV-1 InfectionE-posterB52
MOPEB273 The FRESH acute HIV cohort: Optimized for an HIV cure interventionE-posterB52
MOPEB274 No evidence of neuroaxonal injury following latency reversal with vorinostat and HIV-1 specific vaccination in the RIVER trialE-posterB52
MOPEB275 Clinical and economic impact of ibalizumab for patients with multidrug-resistant HIV in the United StatesE-posterB53
MOPEB276 Malnutrition treatment outcomes of patients receiving RUTF vs peanut butter and fortified blended flour in Mwanza, TanzaniaE-posterB55
MOPEB277 Household food insecurity and nutritional status of HIV-positive individuals on ART in LesothoE-posterB55
MOPEB278 The effects of aerobic exercises on inflammatory markers and depression in people living with HIV undergoing the highly active antiretroviral therapy: A systematic review with meta-analysisE-posterB56
MOPEC317 Effect of strategic Index case testing on HIV case detection in Nigeria: APIN experienceE-posterC1
MOPEC318 HIV care in Turkey: How far Is the UNAIDS 90-90-90 goals?E-posterC1
MOPEC320 Inference of time interval between HIV-1 infection and diagnosis during 2005-2015 in Greece: Implications for testing and control of HIV-1E-posterC1
MOPEC321 Mortality and loss to follow-up in HIV-positive patients starting ART in rural northern Mozambique: The impact of incorporating tracing outcomes on estimates of incidence and associationsE-posterC1
MOPEC322 Gender features of HIV care cascade in 7 countries of Eastern Europe and Central AsiaE-posterC1
MOPEC323 Where do we stand after 4 years of option B+? Community HIV-prevalence and mortality in HIV-exposed children under 4 years in rural southern MozambiqueE-posterC2
MOPEC324 Incidence rate and predictors of HIV incidence among adolescent girls and young women in Lilongwe, MalawiE-posterC2
MOPEC325 Developmental trajectories of transactional sex and age-disparate relationships during adolescence: An HPTN 068 analysisE-posterC2
MOPEC326 Vertically-infected adolescents have poor viral suppression compared to horizontally-infected youthE-posterC2
MOPEC327 Divergent HIV diagnosis rates among Australian- and Asian-born men who have sex with men: Evidence of inequitable access to HIV prevention?E-posterC3
MOPEC328 Profile and HIV prevalence among young men who have sex with men in India: Findings from a large-scale multi-centric cross-sectional surveillance surveyE-posterC3
MOPEC329 HIV prevalence and incidence among men who have sex with men (MSM) attending HIV testing and counselling at a community health care center, Kuala Lumpur, Malaysia 2014-2017E-posterC3
MOPEC330 HIV testing practices and reasons for never-testing among men who have sex with men (MSM) in MalaysiaE-posterC3
MOPEC331 Neglected population? HIV and other STIs burden among transgender people in Nairobi, KenyaE-posterC4
MOPEC332 Characterizing the HIV treatment cascade among transgender women in Kigali, RwandaE-posterC4
MOPEC333 Evaluating differential HIV prevention and treatment outcomes between transgender women and cisgender men who have sex with men in urban centres across CameroonE-posterC4
MOPEC334 A highly-connected risk network position was associated with recent HIV infection approximately three years after the large HIV outbreak began among people who inject drugs (PWID) in AthensE-posterC5
MOPEC335 HCV, HIV/HCV co-infection among people injecting drugs in Tanzania: A hidden epidemicE-posterC5
MOPEC336 HIV prevalence, HIV testing and unrecognized infection among young female sex workers in India: Findings from a large-scale multi-centric cross-sectional surveillance surveyE-posterC6
MOPEC337 Progress toward UNAIDS 90-90-90: Experiences from female sex workers in NigeriaE-posterC6
MOPEC338 HIV risk behavior and testing among people living with sensory disabilities in the United StatesE-posterC7
MOPEC339 HIV epidemiology among the Fisherfolk in the Islands of Lake Victoria in Western Kenya: 2017-2018E-posterC7
MOPEC340 Crystal amphetamine use is common and is associated with HIV infection among MSM and TGW in Bangkok, ThailandE-posterC8
MOPEC341 Determinants of mother to child transmission of HIV among women on the PMTCT programme in Mwenezi district of Masvingo province, ZimbabweE-posterC8
MOPEC342 Intimate partner violence and incident HIV among adolescent girls and young women in rural South Africa: HPTN 068E-posterC8
MOPEC343 The connection between drug use and risk-taking attitudes and behaviors in the context of HIV/STI Epidemic in China - findings from a 2018 Survey of MSM in ChinaE-posterC8
MOPEC344 Male partner age and HIV infection among young women in cohabitating partnerships in five countries in southern AfricaE-posterC8
MOPEC345 A systematic review of risk factors for HIV acquisition during pregnancy and breastfeeding in sub-Saharan AfricaE-posterC8
MOPEC346 Analysis of HCV co-infections among newly diagnosed HIV cases in GermanyE-posterC9
MOPEC347 Knowledge and attitudes around syphilis and syphilis pre-exposure prophylaxis (PrEP) among men who have sex with men in Vancouver, Canada: A qualitative studyE-posterC9
MOPEC348 Genetic network analysis to assess the risk of HIV transmission among MSM seeking partners on the internetE-posterC10
MOPEC349 Detecting outbreak cases in men who have sex with men of a specific age group in Japan by the Search Program of HIV Nation-wide Cluster using Sequence (SPHNCS)E-posterC10
MOPEC350 Characterizing the changing circulating HIV-1 strains in the Philippines to better understand the ongoing epidemicE-posterC10
MOPEC351 Analysis of molecular transmission clusters among newly diagnosed HIV patients in Republic of Panama 2016-2018E-posterC10
MOPEC352 Occupational PrEP for young men who have sex with men and transgender women who exchange sex: Development and implementation of an effectiveness and adherence support open-label study in Bangkok, ThailandE-posterC11
MOPEC353 Alternative RCT designs for microbicides and on-demand HIV prevention productsE-posterC11
MOPEC354 Privacy, confidentiality, and informed consent for HIV phylogenetic research: A case study of urban individuals living with HIV approached for enrollment in an HIV studyE-posterC12
MOPEC355 Conflicting ethical and legal obligations in adolescents HIV prevention research in low resource settings: Medical Research Council of Zimbabwe Ethics Committee ExperiencesE-posterC12
MOPEC356 Beyond U=U: Reducing AIDS mortality further accelerates declines in HIV incidenceE-posterC14
MOPEC357 Potential utility of routine programmatic data in monitoring national and state-level HIV epidemic in Nigeria: Data triangulation analysisE-posterC14
MOPEC358 Impact of targeted pre-exposure prophylaxis uptake among male sex workers on HIV incidence among men who have sex with men: An agent-based modeling studyE-posterC14
MOPEC359 Cost-effectiveness of HIV antiretroviral treatment scale-up among overlapping key populations in Tijuana, MexicoE-posterC14
MOPEC360 Optimal allocation of HIV resources in geographically heterogeneous epidemicsE-posterC14
MOPEC361 The status quo won't suffice: Modeled projections of the HIV/AIDS epidemic across 6 US citiesE-posterC14
MOPEC362 The impact of expanding opioid agonist therapies on HIV epidemic and mortality in Ukraine: A modeling studyE-posterC14
MOPEC363 Factors associated with access to antiretroviral treatment and viral suppression among HIV+ Latin American MSM: Preliminary results of the Latin-American Men Internet Survey (LAMIS)E-posterC15
MOPEC364 Trends in late diagnosis of HIV and time to viral suppression among gay, bisexual and other men who have sex with men (GBM) in Melbourne, AustraliaE-posterC15
MOPEC365 Late diagnosis of HIV new infections in ChileE-posterC15
MOPEC366 Comparison of key findings of the 2013-2014 and 2018 bio-behavioral surveys amongst female sex workers in South AfricaE-posterC15
MOPEC367 Migration and mobility: Correlates of recent HIV testing among female sex workers at the Mexico-Guatemala borderE-posterC15
MOPEC368 Results from a bio-behavioral survey among female sex workers in South Africa: High HIV prevalence and low uptake of HIV-related health servicesE-posterC15
MOPEC369 Sero-prevalence of human immunodeficiency virus and syphilis among pregnant women attending antenatal clinics in Tanzania: Results from ANC sentinel surveillance 2017/2018E-posterC15
MOPEC370 Prevalence and factors associated with virologic suppression among adults and children living with HIV in Lake Victoria island fishing communities in Kenya, 2017/2018E-posterC15
MOPEC371 Partner notification services as a strategy to identify HIV-positive contacts of female sex workers, western KenyaE-posterC16
MOPEC372 A fast track post-exposure prophylaxis (PEP) service delivery model for Thai men who have sex with men (MSM): A prevention opportunity for PEP to pre-exposure prophylaxis (PrEP) transitionE-posterC17
MOPEC373 Incidence in pregnant women attending antenatal clinics in western KenyaE-posterC18
MOPEC374 Inference of the HIV infection dates in Greece using a dense sampling of molecular sequencesE-posterC18
MOPEC375 Using routinely collected data to measure HIV-incidence in high risk populationsE-posterC18
MOPEC376 Exploring differences in empirical incidence data in South African surveys using an agent-based network modelE-posterC19
MOPEC377 Sustained, low prevalence of undiagnosed HIV among gay and bisexual men in Sydney, Australia coincident with increased testing and PrEP use: Results from repeated, bio-behavioural studies 2014-2018E-posterC19
MOPEC378 HIV prevention strategies in Barcelona's Latin American migrants: 68% reduction in incidence reported by BCN CheckpointE-posterC20
MOPEC379 Promising shifts in HIV risk factors and service uptake among young men in EswatiniE-posterC20
MOPEC380 Vertical transmission in the Rwanda PMTCT Cascade: A cross sectional study of HIV-infected children in 2017-2018E-posterC20
MOPED528 Patterns of substance use screening in HIV primary care clinicsE-posterD1
MOPED529 Achieving HIV epidemic control in Zambia: Improving treatment and viral load monitoring coverage in Lusaka urban district through a 'Surge' campaignE-posterD1
MOPED530 Retention in non-facility-based ART delivery models among stable ART patients in Lusaka, Zambia: Findings from the HPTN 071 (PopART) trialE-posterD2
MOPED531 Centralized dispensing and alternative pick up points increase access to ARVs in ZambiaE-posterD2
MOPED532 Differentiated ART delivery for key populations: A systematic reviewE-posterD2
MOPED533 Community Adherence Group (CAG) for HIV viremic patients: Early lessons learnt from Lusaka, ZambiaE-posterD2
MOPED534 Differentiated antiretroviral therapy delivery: A review of implementation progress and challenges in ZimbabweE-posterD2
MOPED535 Back to basics: Friendly health providers are the key to retaining adolescents living with HIVE-posterD3
MOPED536 Improved 12-month ART retention rates through intensive monitoring of key process measures in Zambézia province, MozambiqueE-posterD4
MOPED537 Implementing quality improvement in a large HIV clinic to improve the availability of pediatric viral load results for patient care in rural Zambézia, MozambiqueE-posterD4
MOPED538 Achieving the “third 90” in western Kenya: A quality improvement collaborative (QIC) to improve viral load utilization at 30 health facilities in Siaya County, KenyaE-posterD4
MOPED539 Differentiated Service Delivery (DSD) implementation fidelity: Improving coverage and quality of DSD ART delivery in ZimbabweE-posterD4
MOPED540 A change package for facilitating rapid initiation of ART and early retention in care from a Quality Improvement CollaborativeE-posterD4
MOPED541 A quality improvement collaborative (QIC) approach to improve early infant diagnosis (EID) and antiretroviral therapy (ART) initiation at 25 health facilities in Lusaka urban district, ZambiaE-posterD4
MOPED542 Suppressed viral load among persons on antiretroviral therapy - A case for clinical judiciousness and comprehensive monitoring for persons living with HIVE-posterD4
MOPED543 Engagement of peer navigators in the multidisciplinary team of providers in the same-day antiretroviral therapy initiation hub model in Bangkok, ThailandE-posterD4
MOPED544 Optimizing treatment models for people living with HIV in urban Zimbabwe: Findings from a mixed methods studyE-posterD4
MOPED545 Peer supporters a crucial prong in the HIV response: Perspectives of health providersE-posterD5
MOPED546 Systematic review of the evidence regarding the effectiveness of community-based primary health care in improving HIV/AIDS outcomes for mothers and childrenE-posterD5
MOPED547 Game changer partnerships with non-HEALTH - Civil Society Organizations critical for reaching 90-90-90E-posterD5
MOPED548 Innovative demand creation changes in rolling out oral pre-exposure prophylaxis (PrEP) in Kenya - the Jilinde experienceE-posterD6
MOPED549 The student resource centre model and its impact on student access to HIV related services: A case of Mutare Teachers' College, Mutare, ZimbabweE-posterD6
MOPED550 A culturally sensitive online communication strategy to reach men who have sex with men (MSM) for HIV/STI prevention and testing in South KoreaE-posterD6
MOPED551 Community-led demand creation approaches to improve uptake of safe voluntary medical male circumcision in Eastern UgandaE-posterD6
MOPED552 Leveraging interprofessional student collaboration to educate healthcare providers and increase access to pre-exposure prophylaxis: Results of a novel educational approachE-posterD7
MOPED553 Results from a community mentor mother-led case management of children living with HIV: A case study of USAID's Nilinde ProjectE-posterD8
MOPED554 Reasons why parents are reluctant to disclose their HIV positive status to their children: Lesson learnt in BotswanaE-posterD8
MOPED555 Elimination by the people: A community led approach towards elimination of mother to child transmission of HIV & syphilis. Experience from Global Fund supported Ahana project in IndiaE-posterD8
MOPED556 Effects of malnutrition on ART adherence. Findings from a community HIV project in BotswanaE-posterD8
MOPED557 Standardization of the services provided in HIV from the community, registration, monitoring and evaluation of these within the framework of the Colombian health system, as strategy for maintaining the responseE-posterD8
MOPED558 High uptake and completion of HIV self-testing using a novel community-based delivery strategy for young people in KenyaE-posterD8
MOPED559 Demonstration project of the First Community Led Transgender clinic in the Philippines (Manila)E-posterD8
MOPED560 Impossible to become possible: A journey towards EMTCT; result from plan India's Global Fund supported Ahana project in 9 states of IndiaE-posterD8
MOPED561 Female volunteer community advocates perform at a comparable level with their male counterparts supporting voluntary medical male circumcision (VMMC) services at routine facilities in TanzaniaE-posterD8
MOPED562 Tapping into and maximizing the use of faith worship centers as entry point to HIV prevention services: The experience of Health Kiosk model in ZimbabweE-posterD8
MOPED563 Provider and client-led partner notification service (PNS) approaches on HIV case identification in ZambiaE-posterD9
MOPED564 Community-led assessment of awareness and willingness of HIV self-screening among men who have sex with men (MSM) and transgender women (TGW) in the PhilippinesE-posterD9
MOPED565 Community-led conversations on awareness and acceptability of HIV self-screening among men who have sex with men and transgender women in metropolitan Manila, PhilippinesE-posterD9
MOPED566 Improving PrEP research with transgender women: Lessons from a social network adherence trial in PeruE-posterD9
MOPED567 Correlates of missed visits by participants enrolled in a HIV prevention clinical trial in Eldoret KenyaE-posterD9
MOPED568 Organizational structure of the HIV care continuum in Mexico: A social network analysisE-posterD10
MOPED569 Using expert patients to Scale up HIV Viral Load testing in resource limited settings in United Republic of TanzaniaE-posterD10
MOPED570 I-SURGE, a new implementation strategy to optimize HIV services in Luanda, AngolaE-posterD10
MOPED571 Effects of the community responses program on HIV testing and treatment for men and women: Findings from a randomized controlled trial in informal settlements in KwaZulu-Natal, South AfricaE-posterD11
MOPED572 The Kanyakla study: Randomized controlled trial of a microclinic social network intervention for promoting engagement and retention in HIV care in rural western KenyaE-posterD11
MOPED573 Does intimate partner violence affect implementation of HIV services? A cross-sectional analysis of HIV-infected women in Coastal KenyaE-posterD11
MOPED574 Cost-effectiveness of index HIV self-testing to reach male partners in MalawiE-posterD11
MOPED575 Characteristics of sex workers who have never been tested for HIV: Analysis of bio behavioral data from UkraineE-posterD11
MOPED576 Acceptability of routinely offered paediatric HIV testing at paediatric outpatient clinics in an urban public hospital in Nairobi, KenyaE-posterD12
MOPED577 University clinic HIV testing services versus external service providers' HIV testing services: A study of students' preferences for HIV testing services at 2 State Universities in ZimbabweE-posterD12
MOPED578 Persuaded HIV self-testing during community-based distribution of self-test kits: A population-based survey and nested qualitative study in ZimbabweE-posterD12
MOPED579 Barriers and innovative solutions to achieve the first “90” of HIV care cascade in UkraineE-posterD12
MOPED580 Facility optimization: Use of safe spaces to increase access to HIV testing services among MSM in Kisumu County, KenyaE-posterD12
MOPED581 Routine HIV testing and suicide riskE-posterD12
MOPED582 Comparison of potential effectiveness of universal testing versus index testing: Estimations from 4 years of data from the HPTN 071 (PopART) trialE-posterD12
MOPED583 Utilisation patterns in male focused HIV testing services among rural men in KwaZulu-Natal, South AfricaE-posterD12
MOPED584 Utilization of HIV testing and counselling services (HTS) among female sex workers (FSWs) in a limited resource settingE-posterD12
MOPED585 Rapid test for HIV at the point of care in Buenos Aires City: A strategy for prevention and health promotion outside of the institutional wallsE-posterD12
MOPED586 HIV self-testing in Zambia - an account of early lessons from multi-province program implementation scale-upE-posterD12
MOPED587 Who self-reports never-testing for HIV after community-based distribution of HIV self-testing kits in Malawi, Zambia and Zimbabwe?E-posterD12
MOPED588 LIGHT initiative phase 1: Integration of HIV testing in glandular fever serology ordersets - simple, effective and sustainable intervention to increase HIV testing in line with UK and European guidelinesE-posterD12
MOPED589 Uptake, knowledge, and quality of HIV testing and sexual and reproductive health services among adolescents enrolled in the girls achieve power trial: South AfricaE-posterD12
MOPED590 Too much of a good thing? Prevalence and determinants of frequent HIV testing in Zambia and MalawiE-posterD12
MOPED591 Improving HIV testing and linkage to antiretroviral therapy among men through various male engagement strategies in EswatiniE-posterD12
MOPED592 Partner notification as a strategy to achieve the first 90 in a high-prevalence county in KenyaE-posterD12
MOPED594 Optimizing HIV fast-track strategy in rural communities in north-central Nigeria using prioritized community symptomatic testing (P-COST) model: ImpactE-posterD12
MOPED595 Traditional leaders are the game changers in attainment of 90-90-90 targets in the Sub-Saharan AfricaE-posterD12
MOPED596 Approaches to improving efficiency in HIV case finding: Results from the use of HIV risk assessment checklists in Kogi, North Central NigeriaE-posterD12
MOPED597 The role of peer lay health worker programmes in supporting HIV re-testing among HIV-negative pregnant and breastfeeding womenE-posterD12
MOPED598 Primary prevention of HIV among HIV-negative pregnant and breastfeeding womenE-posterD13
MOPED599 First year of implementation of PrEP in Zambia: Service delivery roll-out and scale-upE-posterD13
MOPED600 Challenges implementing pre-exposure prophylaxis (PrEP) for people who inject drugs in non-urban areas of the United StatesE-posterD13
MOPED601 PrEPare for work: An intervention to increase PrEP uptake among male sex workersE-posterD13
MOPED602 Assessing HIV care outcomes among African-born people living with HIV in Seattle: An analysis of the University of Washington Electronic Medical RecordE-posterD13
MOPED603 Navigating to scale: Results from a national programme for key populations in KenyaE-posterD13
MOPED604 Awareness of PrEP and drivers and barriers to use among men aged 20-34 in Mpumalanga and KwaZulu-Natal, South AfricaE-posterD13
MOPED605 Impact and heterogeneous effects from behavioral economic incentives for improving antiretroviral (ARV) medication adherence in UgandaE-posterD14
MOPED606 Mobile health technology, a revolution towards improving adherence to clinic appointment among PLHIV on antiretroviral therapy in Njombe and Morogoro regions in TanzaniaE-posterD14
MOPED607 A successful individualized communication strategy to enhance retention and ART uptake in naive individualsE-posterD14
MOPED608 Evaluation of an Enhanced Adherence Counseling Model to achieve viral suppression among patients with initial virologic failure: A case study from South-Eastern NigeriaE-posterD14
MOPED609 Integrating mobile phone interventions for adherence support in people living with HIV infection: Contextual difference affects the dynamicsE-posterD14
MOPED610 Depressive symptoms and ART adherence among caregivers of vulnerable children in Southern MalawiE-posterD14
MOPED611 Peer navigation improves HIV care and viral suppression outcomes among South African men who have sex with men; results from a randomized controlled trailE-posterD14
MOPED612 Patient feedback surveys about healthcare workers among women attending PMTCT services in eSwatiniE-posterD15
MOPED613 Reasons for defaulting and prolonging return to care in a cohort of pregnant women reinitiating HIV treatment under Option B+E-posterD15
MOPED615 Suboptimal engagement in HIV care among persons who inject drugs and their partners in Nairobi, KenyaE-posterD15
MOPED616 Improved HIV treatment retention among patients enrolled in a differentiated care model at Kenya General Reference Hospital in Haut Katanga province of the Democratic Republic of the CongoE-posterD15
MOPED617 Mortality and loss to follow-up among HIV positive adolescents and young adults in program settings in KenyaE-posterD15
MOPED618 Characteristics of oral pre-exposure prophylaxis (PrEP) clients with periodic use in the Jilinde program, KenyaE-posterD15
MOPED619 The role of peer lay health worker programmes in improving retention in HIV servicesE-posterD15
MOPED620 Same day ART initiation: Retention into HIV care remains a challenge, a TASO Mbarara experienceE-posterD15
MOPED621 Is loss to follow up (LTFU) as defined by HIV treatment programs a true reflection of client retention in Northern Nigeria?E-posterD15
MOPED622 Open access program to improve engagement in HIV treatment and care services at an urban community health centerE-posterD15
MOPED623 Differentiated service delivery using a “community pharmacy art drug pickup” model: An evaluation from Lusaka, ZambiaE-posterD15
MOPED624 Clinical outcomes of adolescents living with HIV after transitioning to adult care: A systematic reviewE-posterD15
MOPED625 Lost to follow-up tracking drive - Mission ´SAMPARK´ in GujaratE-posterD15
MOPED626 Partner notification services optimize HIV case identification and linkage to treatment among key populations in KenyaE-posterD17
MOPED627 Lottery incentives decrease time to ART initiation for South African men: Results from a randomized pilot studyE-posterD17
MOPED628 Use of mHealth to improve linkage to care outcomes and documentation in population based household SUrveysE-posterD17
MOPED629 Human resources for health increases linkage between HIV testing and treatment in ZimbabweE-posterD17
MOPED630 Optimizing individual and public health benefits of assisted HIV self-testing through effective linkages to services for men who have sex with men and transgender women in LaosE-posterD17
MOPED631 Calculating HIV reactivity rates amongst deferred blood donors at a tertiary hospital in Ghana to exemplify how health services limit progress towards 90-90-90E-posterD17
MOPED632 Alcoholic venue screening: A novel point of engagement with a hard-to-reach population of men for HIV testing and linkage to care in rural South AfricaE-posterD17
MOPED633 Early results from Test and Start implementation in Luanda, AngolaE-posterD17
MOPED634 Interventions to improve linkage to HIV care in the era of "Treat All" in sub-Saharan Africa: A systematic reviewE-posterD17
MOPED635 Non-linkage to care after same-day ART initiation - reasons and acquisition of drug resistance: 24-month follow-up of non-linkers to care from the CASCADE trial in LesothoE-posterD17
MOPED636 Rapid initiation of ART through a Quality Improvement Collaborative in ZimbabweE-posterD18
MOPED637 Adam´s Love 7-Milestones positive journey map: A novel online-to-offline (O2O) HIV care strategy for early linkage to treatment and optimal retention in care among Thai HIV-positive MSME-posterD18
MOPED638 Patient satisfaction feedback (PSF) for ART services in CambodiaE-posterD18
MOPED639 Feasibility and acceptability of a biometric mHealth system for monitoring retention in HIV services and delivering financial incentives to adults initiating antiretroviral therapy in TanzaniaE-posterD19
MOPED640 Viral suppression among HIV patients who receive SMS reminders for clinic appointments: Experience from USAID Boresha Afya program in Southern TanzaniaE-posterD19
MOPED641 Effectiveness of short message service (SMS) reminders on timely pick-up of antiretroviral therapy (ART) among consenting HIV-positive adults in Zambézia province, MozambiqueE-posterD19
MOPED642 Online and now within reach: Survey results for online populations at-risk for HIV in CambodiaE-posterD19
TUPEA001 Genetic characterization HIV-1 sequences from Cabo Verde points to a new sub-subtype AE-posterA1
TUPEA002 Identification of two new HIV-1 BF intersubtype circulating recombinant forms of South American origin, CRF66_BF and CRF75_BF, which also circulate in Southern EuropeE-posterA1
TUPEA003 Near full-length genome sequences of recombinant HIV-1 viruses derived from parental strains expanding in transmission clusters in SpainE-posterA1
TUPEA004 Acquired drug resistance surveillance in HIV-1 treated patients in SenegalE-posterA2
TUPEA005 Impact of CCR2 genetic polymorphisms in HIV acquisition in a Northern Cameroonian pediatric populationE-posterA3
TUPEA006 Upregulation of DNA methylation-dependent repressors ZBTB4 and ZBTB38 in CD4+ T cells from HIV+ patientsE-posterA5
TUPEA034 The replication-competent HIV reservoir is detectable in circulating monocytes and is increased in ART-suppressed chronic HIV-infected individuals with neurocognitive impairmentE-posterA15
TUPEA035 Impact of suppressive cART on reduction of inflammation in the CNS of Chinese-origin rhesus macaques with SIV infectionE-posterA15
TUPEA072 Heterogeneity of HIV co-receptor expression on CD4+ T cell subsets in human rectal mucosal tissuesE-posterA30
TUPEA074 Triterpene derivative NAT-078 as a novel bifunctional HIV-1 entry inhibitorE-posterA35
TUPEA075 In vitro resistance profile of GS-6207, a first-in-class picomolar HIV capsid inhibitor in clinical development as a novel long-acting antiretroviral agentE-posterA35
TUPEA076 Development of a pleuricellular ex-vivo foreskin model of HIV infectionE-posterA35
TUPEA077 Synergistic inhibition of cell-to-cell infection of HIV-1 by the combination of single chain fragment variables (scFvs) and fusion inhibitorsE-posterA35
TUPEA078 Effect of human milk sulfated glycosaminoglycans on HIV-1 infection of human CD4+ cells in vitroE-posterA35
TUPEA096 Rates of HIV-1 virological suppression and patterns of acquired drug resistance among fisherfolk on first-line antiretroviral therapy in UgandaE-posterA50
TUPEA097 Bioinformatic analyses followed by phenotypic assays detect two new mutations associated with patients failing Raltegravir in UgandaE-posterA50
TUPEA098 Accuracy, sensitivity, and specificity of the cobas® Plasma Separation Card on cobas® 8800 System vs DBS on Abbott m2000 for the classification of HIV virological failure as compared to plasmaE-posterA50
TUPEA099 Field evaluation of HIV-1 viral load monitoring in adults and children receiving antiretroviral treatment in Nigeria by dried blood spot testing with realtime HIV-1 on m2000E-posterA50
TUPEA102 Tenofovir alafenamide-releasing nanochannel drug delivery system for PrEPE-posterA53
TUPEA103 Forgiveness of antiretroviral regimens: In vitro HIV-1 viral breakthrough with 2-drug versus 3-drug regimens simulating variable adherence to treatmentE-posterA53
TUPEA104 Abacavir sulphate increases vascular endothelial activation and endothelial-platelet crosstalk: Mechanisms of cardiovascular risk?E-posterA53
TUPEA105 OB-002 (5P12-RANTES) is significantly more potent than other CCR5 antagonists in development for the treatment or prevention of HIV infectionE-posterA53
TUPEA106 Sustained release of cabotegravir from nanochannel delivery implant for HIV PrEPE-posterA53
TUPEA107 Association between Integrase Strand Transfer Inhibitors and serummagnesium levelsE-posterA55
TUPEA108 Functional expression of antiretroviral drug efflux transporters and metabolic enzymes in human peripheral and testicular T cell subsetsE-posterA55
TUPEA109 Drug efflux transporters and metabolic enzymes in circulating myeloid cells of HIV-infected individualsE-posterA55
TUPEA110 The role of Raltegravir alone or combined with lamivudine as PrEP: A Phase 2 randomised controlled clinical trialE-posterA55
TUPEA111 Targeting lopinavir to gut-associated lymphoid tissue by lipophilic prodrug approach for improved treatment of HIV/AIDSE-posterA55
TUPEB142 Evaluation of a computerized neuropsychological test battery for diagnosing HIV-associated neurocognitive disorders (HAND)E-posterB13
TUPEB143 Performance evaluation of automated real-time PCR assays for diagnosis of TB in HIV infected individualsE-posterB13
TUPEB144 Pulmonary arterial hypertension in HIV positive patients in a low income countryE-posterB13
TUPEB145 Point-of-care cryptococcal antigen screening predicts cryptococcal meningitis and mortality among people living with HIV in a South African TownshipE-posterB13
TUPEB146 Patient and health system factors associated with pretreatment loss to follow up among patients diagnosed with tuberculosis using Xpert® MTB/RIF testing in UgandaE-posterB13
TUPEB147 Diagnostic performance of Xpert MTB/RIF for pulmonary tuberculosis screening in AIDS-associated Kaposi sarcoma in ZimbabweE-posterB13
TUPEB150 Kaposi´s Sarcoma Herpesvirus (KSHV) in Cuba: Prevalence and molecular epidemiologyE-posterB15
TUPEB151 The changing epidemiology of HIV-associated adult meningitis, Uganda 2015 - 2017E-posterB15
TUPEB152 CD4 count-based guidelines for tuberculin skin testing and tuberculosis preventive therapy in people living with HIVE-posterB16
TUPEB153 Changes of NK cell repertoire related to the onset of immune reconstitution inflammatory syndrome In TB/HIV co-infectionE-posterB16
TUPEB154 Impact of late presentation and late ART initiation on TB incidence across four countriesE-posterB16
TUPEB155 Incidence and predictors of active tuberculosis among HIV-infected adults receiving long term antiretroviral therapy in ThailandE-posterB16
TUPEB156 Diagnostic features of tuberculosis peritonitis in HIV-positive patientsE-posterB16
TUPEB157 High programmatic isoniazid preventive therapy (IPT) use in pregnant HIV-infected women including periconception and early pregnancy initiationE-posterB16
TUPEB158 ART initiation within 8 weeks of TB treatment Leads to superior TB outcomes in ART-naïve children and adolescents living with HIV: Results from six high TB/HIV burden countriesE-posterB16
TUPEB159 Evaluation of the World Health Organization (WHO) 4 symptom screening for intensified Tuberculosis (TB) case finding among people living with HIV (PLHIV) in IndiaE-posterB16
TUPEB161 Identification of biomarkers to predict disease progression at time of TB diagnosisE-posterB16
TUPEB162 Treatment outcomes of HIV-TB co-infected children below 18 years of age: A cohort studyE-posterB16
TUPEB163 Severe adherence challenges in the treatment of multi- and extensively drug resistant tuberculosis and HIV: Electronic dose monitoring and mixed methods to identify and characterize high-risk subpopulationsE-posterB16
TUPEB164 Examining isoniazid concentrations in hair as a novel metric of adherence among HIV/TB co-infected persons receiving TB prophylaxis in UgandaE-posterB16
TUPEB165 Prevalence of latent tuberculosis infection in HIV-infected patients using tuberculin skin test and Interferon-Gamma Release AssayE-posterB16
TUPEB166 Characteristics and risk of mortality among TB/HIV co-infected patients at a large HIV clinic in the era of test and treat in UgandaE-posterB16
TUPEB167 In silico prediction of major histocompatibility complex (MHC) class II epitopes associated with hepatitis B virus (HBV) infection in BotswanaE-posterB17
TUPEB168 Cell-associated HIV DNA levels in peripheral blood similar among hepatitis B and C virus coinfected and HIV mono-infected Chinese patientsE-posterB17
TUPEB169 Continued virological benefits but stabilised HBsAg loss after 8 years of tenofovir-inclusive ART regimens in HIV-HBV co-infectionE-posterB17
TUPEB170 Inflammatory markers associated with mortality in HIV-positive individuals from Côte d'Ivoire: Role of HIV-HBV co-infectionE-posterB17
TUPEB171 An investigation of the mechanisms and changes in chronic immune activation in patients with HIV/HBV co-infection after receiving HAARTE-posterB17
TUPEB172 Effectiveness of generic direct-acting agents to HCV treatment: A systematic review and meta-analysisE-posterB18
TUPEB173 Incidence of hepatitis C virus infection among HIV-positive men in Singapore: Trends and epidemiological risk factorsE-posterB18
TUPEB174 Use of the HCV-MOSAIC risk score for identification of hepatitis C virus (HCV) reinfection in HIV-infected men who have sex with men (MSM)E-posterB18
TUPEB175 Self-reported risk factors to better predict HCV infection in general populationE-posterB18
TUPEB176 Hepatitis C virus co-infection and the risk of peripheral artery disease among HIV-infected patients: Population-based studyE-posterB18
TUPEB177 Characteristics of patients diagnosed with hepatitis C across different care settings: Implications for improving diagnosis and linkage to careE-posterB18
TUPEB178 Association between tenofovir disoproxil fumarate exposure and reduced bone mineral density in a cohort of HIV-positive patients: Results from 21 years of follow-upE-posterB18
TUPEB179 Treatment outcome of simplified HCV testing and generic sofosbuvir/velpatasvir in Myanmar (USAID/EQUIP project)E-posterB18
TUPEB180 Correlates of unsuccessful HCV therapy: HIV co-infected vs. HCV mono-infected people who use drug (PWUD)E-posterB18
TUPEB181 Predictors of decreasing bone mineral density after switching from TDF to TAF in Japanese subjects with HIVE-posterB18
TUPEB182 High risk human papillomavirus oral infection in people with HIV/AIDS, before and after combined antiretroviral therapy initiationE-posterB21
TUPEB183 Incidence rate of high-grade anal squamous Intraepithelial Neoplasia (HG-AIN) among HIV-infected and high risk men who have sex with men (MSM) in resource-limited settingsE-posterB21
TUPEB184 Genotypic diversity of anal HPV amongst HIV-infected women reporting for routine cervical cancer screening in Harare, ZimbabweE-posterB21
TUPEB185 Factors associated with sexually transmitted infections among HIV-positive clients in same-day antiretroviral therapy cohort in Bangkok, ThailandE-posterB22
TUPEB186 Clinical prediction of neurosyphilis in HIV-infected patients with early syphilisE-posterB22
TUPEB187 Quick Sequential Organ Failure Assessment score predicts mortality among hospitalized patients with HIV/AIDSE-posterB23
TUPEB188 Schistosomiasis is not a strong risk factor for HIV acquisition in four prospective cohorts: A nested case-control analysisE-posterB23
TUPEB189 Cross-talk between H.pylori and gastric microbiome among people living with HIVE-posterB23
TUPEB190 Bloodstream infection (BSI) in HIV-infected and HIV-uninfected patients in a tertiary hospital in Barcelona, Spain: A 16-year comparative studyE-posterB23
TUPEB191 Shorter CD8 T cell subset telomeres and lower proliferative: Senescent CD8 ratio in people with chronic/latent viral coinfectionsE-posterB23
TUPEB192 Parkinson's disease diagnoses in a population-based cohort of people living with HIV and a comparative general population sample in British Columbia, CanadaE-posterB24
TUPEB193 CSF viral escape among HIV-infected patients in Southern IndiaE-posterB24
TUPEB194 Co-morbidity of HIV and psychosis among the In-patients at the national tertiary psychiatric hospital in MalawiE-posterB25
TUPEB195 Role of immune suppression as independent prognostic factor of NHL outcome in PLWHIVE-posterB26
TUPEB196 Malignancies' standardized incidence rates among adults' Hispanic people living with HIV in the recent cART era, Puerto Rico 2010-2015E-posterB26
TUPEB197 First report on salivary shedding, viremia and seroprevalence of Kaposi´s sarcoma associated herpes virus among a group of men who have sex with men and transgender women from ArgentinaE-posterB26
TUPEB198 Improving access to cervical cancer screening services at remote areas in TanzaniaE-posterB26
TUPEB199 Head and neck cancers in U.S. Veterans living with HIVE-posterB26
TUPEB200 Gut microbial dysbiosis in HIV-infected males with different sexual behaviour and cardiovascular riskE-posterB27
TUPEB201 Cardiovascular disease risk among HIV-infected and uninfected adults in Kisumu, KenyaE-posterB27
TUPEB202 Framingham, EURO and asCVD risk scores perform less good in HIV+ individuals from the HIVH-study compared to the general populationE-posterB27
TUPEB203 Impact of HIV specific and traditional risk factors on the incidence of cardiovascular events in HIV-positive males over timeE-posterB27
TUPEB204 Longitudinal analysis of blood pressure and estimation of the effect of HIV on BP mediated through HIV-specific pathways in a mixed cohort in UgandaE-posterB27
TUPEB206 Estimated glomerular filtration rate (eGFR) Slopes on Tenofovir Alafenamide (ESTA)E-posterB29
TUPEB207 Renal function with dolutegravir, elvitegravir/cobicistat, raltegravir, or darunavirE-posterB29
TUPEB208 Outcome of early-switching of Tenofovir Disoproxil Fumarate (TDF) in HIV-infected patients with TDF-induced nephrotoxicity: A prospective studyE-posterB29
TUPEB209 Real-world eGFR change among HIV patients who switch from F/TDF to F/TAF while maintaining the same third agent classE-posterB29
TUPEB210 Prevalence and associated risk factors for diabetes at HIV diagnosis in South AfricaE-posterB30
TUPEB211 Switch from tenofovir to raltegravir is not associated with weight gain over 96 weeksE-posterB30
TUPEB212 HIV+ women with diabetes mellitus exhibit CD4+ T lymphocyte immunometabolic dysfunctionE-posterB30
TUPEB213 Abnormal liver function tests are common during acute HIV infection, correlate with HIV viral load, and do not persist in individuals initiating antiretroviral therapyE-posterB31
TUPEB214 The physical and mental health implications of vision impairment in aging HIV-infected menE-posterB32
TUPEB215 Low muscle mass is the body composition parameter most predictive of pre-frailty and frailty in Asians living with HIVE-posterB32
TUPEB216 Characterizing Canadians living with HIV to improve management of comorbiditiesE-posterB32
TUPEB217 Smoking and High HIV viremia damage mitochondrial DNA and may accelerate mtDNA agingE-posterB32
TUPEB218 Depression is associated with greater telomere attrition over time in HIV-infected women- implications to aging in long living women with HIV infectionE-posterB32
TUPEB219 Dolutegravir is associated with Kaposi Sarcoma's Immune Reconstitution Inflammatory syndrome in a cohort of AIDS patients in Rio de Janeiro, BrazilE-posterB33
TUPEB220 Elevated anti-CMV IgG titer is associated with microbial translocation in elite controllers and ART-treated people living with HIVE-posterB33
TUPEB221 Gastrointestinal disorders following initiation of dolutegravir, elvitegravir, raltegravir or darunavirE-posterB35
TUPEB222 Prevalence and outcomes for heavily treatment-experienced (HTE) individuals living with HIV in a European CohortE-posterB35
TUPEB303 Long-term growth among children stunted at ART initiation in MalawiE-posterB70
TUPEB309 High prevalence of anal and oral high risk-human papillomavirus in HIV-negative French men who have sex with men taking pre-exposure prophylaxisE-posterB76
TUPEC381 Development of a scale to assess male partner involvement in the prevention of mother-to-child transmission of HIVE-posterC24
TUPEC382 Reasons for exclusion from voluntary medical male circumcision: Project IQ Malawi experienceE-posterC25
TUPEC383 Maximizing voluntary medical male circumcision for HIV prevention in Lilongwe, Malawi, by targeting men in priority age group (15-29 years)E-posterC25
TUPEC384 Modeling the impact of Voluntary Medical Male Circumcision (VMMC) on cervical cancer in UgandaE-posterC25
TUPEC385 Post-exposure prophylaxis in victims of sexual violence. 10 years' experience at the Condesa Specialized Clinic (CSC)E-posterC26
TUPEC386 Eighteen years experience of prophylaxis after sexual exposure to HIV (PEP): Comparison between two decadesE-posterC26
TUPEC387 Zero: The seroconversion rate of Mozambican health workers occupationally exposed to HIVE-posterC26
TUPEC388 Use of HIV postexposure prophylaxis after sexual assault among female sex workers in BrazilE-posterC26
TUPEC389 Awareness of HIV Postexposure Prophylaxis among female sex workers in BrazilE-posterC26
TUPEC390 Projected impact of concurrent availability of long-acting injectable and daily-oral PrEP among men who have sex with menE-posterC27
TUPEC391 PrEP users perceive high community-level PrEP stigma in KenyaE-posterC27
TUPEC392 Level of polysubstance use is associated with increased sexually transmitted infections but not with decreased PrEP adherence in MSME-posterC27
TUPEC393 A pooled analysis of the effect of adherence on the renal safety of FTC/TDF (Truvada) for PrEP: 7 international demonstration projectsE-posterC27
TUPEC394 Temporal dynamics of sexual behaviour among MSM on sequential daily and event-driven PrEP: Results from a crossover studyE-posterC27
TUPEC395 Factors associated with increased condomless sex in a PrEP adherence trial: Possible clues into who is most at riskE-posterC27
TUPEC396 Pre-exposure prophylaxis and STIs screenings in the Dominican Republic: Is an integrated approach necessary to scale-up?E-posterC27
TUPEC397 Indications for PrEP and engagement along the PrEP continuum among emerging adult men who have sex with men in the Mid-Atlantic United StatesE-posterC27
TUPEC399 Awareness and willingness to use PrEP among female sex workers in Dar-es-SalaamE-posterC27
TUPEC400 Latent class analysis of current use and willingness of adopting pre-exposure prophylaxis in men who have sex with men in Taiwan: Subgroup analysis from 2017 Hornet/HEART SurveyE-posterC27
TUPEC401 Homelessness at diagnosis is the strongest predictor of death among persons with HIV in a population-based study of a U.S. cityE-posterC27
TUPEC402 PrEP knowledge and attitudes among adults attending public health clinics in Southern ArizonaE-posterC27
TUPEC403 Differences in adherence to TDF/FTC for PrEP in community health centers in the US: Medication Adherence Sub-study (MAS) of the Sustainable Health Center Implementation PrEP Pilot (SHIPP)E-posterC27
TUPEC404 Can we believe the patient's estimates? A comparison between measured treatment adherence and patient-estimated treatment adherence by patients enrolled in a PrEP pilot study in the Dominican RepublicE-posterC27
TUPEC405 Utilization of Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF) for HIV pre-exposure prophylaxis (PrEP) in the United States by age, gender and ethnicity (2014 - 2017)E-posterC27
TUPEC406 Factors affecting adherence to HIV pre-exposure prophylaxis (PrEP) among female sex workers taking PrEP in Kampala, UgandaE-posterC27
TUPEC407 Use of HIV pre-exposure prophylaxis reduces HIV anxiety among high risk gay and bisexual menE-posterC27
TUPEC408 Baseline and early follow up in the My PrEP study: A pilot PrEP demonstration project in high risk men who have sex with men (MSM) in Kuala Lumpur, MalaysiaE-posterC27
TUPEC409 Key population-delivered oral pre-exposure prophylaxis: Initial enrollment, adherence and retention results among men who have sex with men in VietnamE-posterC27
TUPEC410 Precedent factors in association with using PrEP event-driven over daily dosing regimen among men who have sex with men in Taiwan: A mixed-effect model analysisE-posterC27
TUPEC411 Condomless anal intercourse and adequacy of protection from HIV pre-exposure prophylaxis (PrEP) in the EPIC-NSW trialE-posterC27
TUPEC412 Preliminary findings on pre-exposure prophylaxis uptake and continuation among female sex workers and men who have sex with men in Thika, KenyaE-posterC27
TUPEC413 Modeling parallel reductions in anxiety and HIV worry among PrEP users: Evidence for mental health benefits of PrEP implementationE-posterC27
TUPEC414 PrEP awareness and potential/actual use among MSM at risk for HIV infection in the Latin American MSM Internet Survey (LAMIS)E-posterC27
TUPEC415 Factors associated with PrEP Use and willingness to use PrEP among MSM at risk for HIV infection in the Latin American MSM Internet Survey (LAMIS)E-posterC27
TUPEC416 Challenges and barriers to PrEP implementation in public health facilities in Latin America: Initial lessons from the ImPrEP demonstration project in PeruE-posterC27
TUPEC417 The awareness of and willingness to use pre-exposure prophylaxis among men who have sex with men in ChinaE-posterC27
TUPEC418 TDF/FTC pre-exposure prophylaxis (PrEP) from 2012 to 2018 in the OPERA cohortE-posterC27
TUPEC419 Pre-exposure prophylaxis (PrEP) in Spain: 24-week results after of the feasibility study for PrEP implementationE-posterC27
TUPEC421 PrEP use among MSM in Brazil: First results from Latin America MSM Internet Survey (LAMIS)E-posterC27
TUPEC422 Awareness and willingness to use PrEP among men who have sex with men in Mexico, Encuesta de Sexo Entre Hombres, 2017E-posterC27
TUPEC424 Longitudinal analysis of renal function among participants in a large Australian PrEP demonstration study, PrEPXE-posterC27
TUPEC425 Model-based comparison of the individual-level and community-level benefits of PrEP in South Africa: Implications for priority populationsE-posterC27
TUPEC426 “I always use condoms - with that one” - different risk compensation dynamics in different population groups: Evidence from a qualitative study of PrEP clients in EswatiniE-posterC27
TUPEC427 Longitudinal changes in condom use with casual partners among gay and bisexual men using HIV pre-exposure prophylaxisE-posterC27
TUPEC428 HIV infection after stopping PrEP in a U.S. safety-net integrated health system: A mixed methods studyE-posterC27
TUPEC429 The global PrEP research landscape: Mapping studies of oral PrEP implementation and impactE-posterC27
TUPEC430 Initiation and persistence of oral pre-exposure prophylaxis (PrEP) by adolescent girls and young women (AGYW) for HIV prevention in KenyaE-posterC27
TUPEC431 Tracking oral PrEP access globally: Using initiation trend data to inform product introductionE-posterC27
TUPEC432 Change in awareness of, willingness to and utilization of PrEP over the past two years in JapanE-posterC27
TUPEC433 PrEP as a potential solution in Yangon, Myanmar to address high behavioral risk for HIV acquisition among men who have sex with men and transgender women: A mixed-methods assessmentE-posterC27
TUPEC434 Short-term adherence marker to PrEP is strongly associated with future discontinuation in a large PrEP Demo Project in the U.S: Implications for point-of-care urine adherence testingE-posterC27
TUPEC435 Barriers to and facilitators of PrEP uptake: Lessons from FHI 360/Ministry of Health demonstration Project in the Kingdom of EswatiniE-posterC27
TUPEC436 Longer term PrEP users in a Boston community health center: Sociodemographic factors and PrEP persistenceE-posterC27
TUPEC437 Barriers and facilitators of PrEP use: A synthesis of proceedings of the Empowering Women´s Health Summit, Miami, FL, 2018E-posterC27
TUPEC438 PrEP uptake, engagement, and adherence following population-wide HIV testing in rural Kenya and Uganda in the SEARCH studyE-posterC27
TUPEC439 Identifying and addressing barriers to pre-exposure prophylaxis initiation via telecommunication intervention in urban NYCE-posterC27
TUPEC440 Determinants of PrEP uptake in the general population in EswatiniE-posterC27
TUPEC441 Mapping the need and benefit of PrEP in three African countries to estimate programmatic targetsE-posterC27
TUPEC442 Leveraging mobile health to promote uptake, retention and success of elimination of mother to child transmission of HIV (EMTCT) in Uganda, 2016 -2017E-posterC29
TUPEC443 Awareness, preferences, and willingness to pay for HIV self-tests in KenyaE-posterC33
TUPEC444 Immune biomarkers are associated with HIV exposure or infection in children using DBSE-posterC33
TUPEC445 Factors associated with acceptability of HIV self-testing among men who have sex with men in 12 Brazilian citiesE-posterC33
TUPEC446 Stakeholders perceptions towards implementing HIV self-testing as an assisted partner services strategy to reach men in HaitiE-posterC33
TUPEC447 Uptake of HIV self-testing among key populations taking HIV pre-exposure prophylaxis in central UgandaE-posterC33
TUPEC448 Retesting for HIV on antiretroviral therapy (ART) against policy recommendations: Investigating the impact on sensitivity of self-testing, Blantyre, MalawiE-posterC33
TUPEC449 HIV self-testing method preferences among men who have sex with men in TaiwanE-posterC33
TUPEC450 Factors influencing HIV self-testing amongst men who have sex with men (MSM) in Singapore - Understanding barriers and motivators using the Protection Motivation Theory (PMT) frameworkE-posterC33
TUPEC451 HIV self-testing: Assessing potential to improve efficiency of community-based index case testing in Mwenezi district, ZimbabweE-posterC33
TUPEC452 Value of secondary distribution of HIV self-test kits to male partners of female sex workersE-posterC33
TUPEC453 Value of secondary distribution of HIV self-test kits to male partners of women attending antenatal clinicsE-posterC33
TUPEC454 Leaving no one behind: Demonstration project of HIV self-testing among men who purchase sex in IndonesiaE-posterC33
TUPEC455 High feasibility and acceptability for HIV self-testing among men who have sex with men, male sex workers, and transgender people in NepalE-posterC33
TUPEC456 Perceptions of HIV self-testing to support PrEP delivery among Kenyan PrEP usersE-posterC33
TUPEC457 Facilitators and barriers toward HIV self-testing among transgender women in Mumbai and Delhi, IndiaE-posterC33
TUPEC458 Identification of HIV-positive partners and changes in sexual behavior following secondary distribution of HIV self-tests by high-risk women in KenyaE-posterC33
TUPEC459 Maternal factors for adherence in infant isoniazid preventive therapy provision among HIV-exposed uninfected infants (HEU) in KenyaE-posterC34
TUPEC460 Acceptability and willingness to pay for hepatitis C virus services in VietnamE-posterC34
TUPEC461 Knowledge and attitudes toward human papillomavirus (HPV), HPV vaccine and cervical cancer among female students in Chittagong, BangladeshE-posterC34
TUPEC463 High prevalence of HIV, syphilis and HCV among key populations and their partners: Results from an integrated multiple diseases testing led by community in VietnamE-posterC35
TUPEC464 Variability in comprehensiveness of sexual health care and HIV preventionE-posterC35
TUPEC465 Prevalence of sexually transmitted infections in pregnant women and their partners in Porto Alegre, BrazilE-posterC35
TUPEC466 Trends for the future: Binational HIV risk patterns among women who inject drugs living on the U.S.-Mexico borderE-posterC35
TUPEC467 Human papillomavirus type distribution in head and neck: A meta-analysis from infection to cancer among HIV-negative and HIV-positive patientsE-posterC35
TUPEC468 Using continuous quality improvement interventions to increase the effectiveness of assisted partner notification services in Kisumu, KenyaE-posterC36
TUPEC470 Maximizing HIV testing yield through index partner testing using assisted partner notification approach: Implementation progress in UgandaE-posterC36
TUPEC471 The 4 youth by youth HIV self-testing contest: A crowdsourced contest to promote HIV self-testing among young people in NigeriaE-posterC36
TUPEC472 High rate of peripartum virological suppression and its significant implications for elimination of mother-to-child transmission of HIV in resource-constrained settings of Eastern Cape, South Africa: Population-based cohort studyE-posterC37
TUPEC473 Approaching eMTCT in Zimbabwe: Expansion of PMTCT services and declining MTCT, 2012-2018E-posterC37
TUPEC474 Why is there still high maternal to infant HIV transmission where PMTCT services are available? Analysis of service data from 77 health facilities in rural and semi-urban KenyaE-posterC37
TUPEC475 A systematic review and meta-analysis of HIV incidence during pregnancy and breastfeeding in sub-Saharan AfricaE-posterC37
TUPEC476 Who seeks safer conception care in rural Uganda? A call for client-centred care for men and women affected by HIVE-posterC37
TUPEC477 Committed, effective and consistent leadership for a sustained PMTCT program in Cameroon: The case of the Cameroon baptist convention health board (CBCHB)E-posterC37
TUPEC478 Measurement system analysis: HIV rapid test interpretation in prenatal care in MexicoE-posterC37
TUPEC480 The effect of HIV and antiretroviral treatment on pregnancy rates in the Western Cape province of South Africa: Findings from a health service linkage studyE-posterC38
TUPEC481 Willingness to use pre-exposure prophylaxis (PrEP) for HIV prevention and PrEP implementation preferences among transgender women in Malaysia: A cross-sectional studyE-posterC40
TUPEC482 Pre-exposure prophylaxis (PrEP) indication, use, and adherence among transgender women in six U.S. cities: Interim findings from the LITE cohort, 2018E-posterC40
TUPEC483 Integration of HIV prevention and primary care for gay, bisexual, and other men who have sex with men in Puerto RicoE-posterC41
TUPEC484 Improved partnership stability while participating in a safer conception program - Perspectives from HIV serodiscordant couples in KenyaE-posterC42
TUPEC485 “She takes hers and I take mine”: Experiences of HIV serodiscordant couples using safer conception strategies in Thika, KenyaE-posterC42
TUPEC486 How better predict MSM becoming HIV-infected in West Africa? A combined approach of sexual behavior (CohMSM ANRS 12324 - Expertise France)E-posterC43
TUPEC487 Quality of health care for key population: Mixed method study among service providers using Donabedian modelE-posterC43
TUPEC488 Expanding HIV testing among hard-to-reach populations through index testingE-posterC43
TUPEC489 Innovative HIV testing strategy with Burundian female sex workers: Enhanced peer outreach approach to improve case detection by comparing outcomes between recruitment chains of HIV-positive and unknown HIV serostatus peersE-posterC43
TUPEC490 Characteristics of younger MSM and association of age with PrEP awareness and willingness in Brazil, Mexico and PeruE-posterC44
TUPEC491 Novel online technology to reach individuals at risk of HIV with HIV testing services in NepalE-posterC44
TUPEC493 Tailored, adolescent-friendly mobile clinic sexual health services are convenient, trust-building, and highly preferred over conventional clinics: Investigating acceptability of a youth-directed sexual health services in Cape Town, South AfricaE-posterC45
TUPED643 Clinical and economic benefits of multi-disease testing on GeneXpert platform in a public health system in Malawi: An observational studyE-posterD20
TUPED644 Integrated TB/HIV care and treatment improves outcomes among children and adolescents living with HIVE-posterD20
TUPED645 Regional progress in achieving 75% reduction in AIDS-related TB deaths: Will we achieve the 2020 target?E-posterD20
TUPED646 Chronic HIV and Non-Communicable Diseases (NCD) care management in Uganda: An observation study to describe provision of basic servicesE-posterD21
TUPED648 Substance use services in HIV clinics: Data from the global IeDEA consortium, 2014 and 2017E-posterD21
TUPED649 Modeling the cost-effectiveness of antenatal dual HIV/syphilis testing in in KenyaE-posterD22
TUPED650 Evaluation of a dedicated postnatal contraception clinic for women living with HIV (WLWH): 5 years post-implementationE-posterD22
TUPED651 Factors influencing potential adoption of PrEP services in title X-funded family planning clinics in the Southern United StatesE-posterD22
TUPED652 Integrating family planning services into HIV care in Zambia: Baseline resultsE-posterD22
TUPED653 Effects of peer counseling intervention on access and use of sexual and reproductive health services in women living with HIV in Nepal: A prospective cohort studyE-posterD22
TUPED654 Examining early postpartum uptake of contraceptives among women with HIV in the context of family planning and HIV services integration in South AfricaE-posterD22
TUPED655 Community intervention partners (CIPs), an innovative cost effective model to promote behavioral change among HIV positive drug abusers in Wakiso District, UgandaE-posterD23
TUPED656 Implementation of integrated patient-centered care for women presenting late with advanced HIV disease in NigeriaE-posterD23
TUPED657 In the aftermath of AIDS denialism era in South Africa: Perspectives and outcomes of integrated PMTCT services at primary health care levelE-posterD23
TUPED658 Tracking integrated malnutrition and HIV outcomes: Cohort analysis of integrated service provision, Gweru district, ZimbabweE-posterD23
TUPED659 Integrating health services provision - Improving HIV testing and treatment for children under five years referred to rural health facilities with severe acute malnutritionE-posterD23
TUPED660 Intervention to reduce the Cervical Cancer Screening Gap in women with HIV from the Condesa Iztapalapa Specialized Clinic in Mexico CityE-posterD23
TUPED661 Understanding the financial lives of female sex workers in Addis Ababa, Ethiopia: Implications for economic strengthening interventions for HIV preventionE-posterD24
TUPED662 Mobile client driven DSD: Strategies employed to support continuity of HIV treatment among mobile clientsE-posterD25
TUPED663 Increased rate of antiretroviral-resistance associated mutations in Human Immnunodeficiency Virus infecting Mexicans with a background of stay in a foreign countryE-posterD25
TUPED664 Factors associated with increased social deprivation among older people living with HIV (PLHIV)E-posterD28
TUPED665 The prevalence of current alcohol use and risky drinking among patients receiving antiretroviral therapy in Dar es Salaam, TanzaniaE-posterD28
TUPED666 Community advisory boards role in accelerating optimal HIV treatmentE-posterD29
TUPED667 The grantees as catalysts for collaborative governance in HIV/AIDS care and treatment in the U.S.: The EMAs' experienceE-posterD29
TUPED668 Leveraging a novel HIV/Syphilis Duo assay to increase diagnoses among female sex workers at drop-in centres in CameroonE-posterD30
TUPED669 Uptake and performance of blood-based self-testing versus oral fluid-based self-testing in Blantyre district, MalawiE-posterD30
TUPED670 “Knowing One's Truth” - user and non-user experiences with HIV self-testing in Kenya: A qualitative studyE-posterD30
TUPED671 Index HIV self-testing among male partners in Malawi: Predictors of self-testing within a randomized controlled trialE-posterD30
TUPED672 Complexity outside the box: Challenges faced by HIV rapid diagnostic tests in a non-profit testing program in MexicoE-posterD30
TUPED673 Acceptability of Cepheid Xpert HIV-1 Qual assay (Xpert HIV) in early infant diagnosisE-posterD30
TUPED674 Uptake and utilization of viral load test results for improved patient management in selected facilities in Central UgandaE-posterD33
TUPED675 Low invalid rates observed with point-of-care CD4 testing in decentralized high HIV burden settingsE-posterD32
TUPED676 Feasibility of point-of-care viral load testing in postpartum HIV-positive women in South Africa: Interim resultsE-posterD32
TUPED677 The acceptability of introducing rapid tests for HIV and sexually transmitted infections in the real-world: A systematic review of qualitative researchE-posterD32
TUPED678 Acceptability of point-of-care viral load testing to facilitate differentiated HIV care: A qualitative study amongst people living with HIV and healthcare workers in South AfricaE-posterD32
TUPED679 Availability of HIV point-of-care diagnostic tests in rural Ghana's primary healthcare clinics: An audit of inventory managementE-posterD32
TUPED680 Economic analyses of hepatitis C responses: Charting the paths, costing the stepsE-posterD34
TUPED681 The journey to self-reliance: Sustainable economic empowerment in NamibiaE-posterD34
TUPED682 Implementation of WHO plant to use integrase inhibitors in first-line HIV treatment: Middle-income setting experienceE-posterD34
TUPED683 Sustainability of mHealth interventions: Patients´ preferences and willingness to pay user fees for mHealth ART adherence support tool in resource limited settingE-posterD35
TUPED684 Willingness to accept/willingness to pay ratios of prevention of mother-to-child transmission services in a Nigerian hospital: A cross-sectional contingent valuation studyE-posterD35
TUPED685 Health systems effects of strengthening human resource for HIV service delivery in pre-service training institutions: Experience from a government-NGO-donor collaboration in NigeriaE-posterD38
TUPED686 HIV funding in the Republic of Congo: Assessment of free careE-posterD39
TUPED687 Transitioning from international funding to domestic health financing to support key population-led health services in Thailand: The Songkhla modelE-posterD40
TUPED688 Pay-it-forward integrated HIV/STD testing for men who have sex men: A mixed methods pragmatic studyE-posterD40
TUPED689 Increasing the efficiency and cost-effectiveness of HIV community outreach through pay-for-performanceE-posterD40
TUPED690 Determinants of willingness to participate in community-based health insurance among people living with HIV in a large tertiary hospital in South-east NigeriaE-posterD40
TUPED691 DTG or not to DTG? Health-system stakeholder perceptions on Dolutegravir to optimise guideline implementation in ZimbabweE-posterD41
TUPED692 Changing sexual dynamics among young men in Mumbai, India - need for innovative prevention strategiesE-posterD41
TUPED693 Effectiveness of a 5-point modular training program for health providers in achieving holistic care for PLHIV who use drugs in the Philippines: A pilot studyE-posterD42
TUPED694 A cross-sectional study on levels of knowledge on provision of second-line antiretroviral therapy in Malawi in 2016E-posterD42
TUPED695 An assessment of health care facilities compliance to environmental and social safeguards - a case study of HIV/AIDs programme development project II (HPDP II) NigeriaE-posterD43
TUPED696 Improving HIV/AIDS response coordination in Nigeria through the use of the Geographic Information System (GIS)E-posterD43
TUPED697 What IF? Implementation fidelity (IF) for improving HIV program performance in ZimbabweE-posterD43
TUPED698 Accelerating implementation of HIV-related stigma and discrimination reduction activities in healthcare settings: A learning network approach in Cambodia, Lao PDR, Thailand, and VietnamE-posterD43
TUPED699 Improving rapid ART initiation in Blantyre, Malawi, through implementation of a quality improvement collaborativeE-posterD43
TUPED700 Improved HIV testing efficiency in Zambia through enhanced real-time program surveillanceE-posterD43
TUPED701 Ensuring real-world comparability in a pragmatic implementation trial of eHealth HIV prevention intervention for young men who have sex with men (YMSM)E-posterD43
TUPED702 Using KP-MoH integrated service delivery approach to promote MSM comprehensive HIV service uptake among MSMs in Machakos CountyE-posterD44
TUPED703 Stigma and discrimination in key population in the health sector: The Mozambique experienceE-posterD44
TUPED704 Factors promoting uptake of drop-in center services by female sex workers in Thika, KenyaE-posterD44
TUPED705 Male engagement - effective strategy towards Reduction of Socio-structural barriers to ART adherence and retention among females in North West NigeriaE-posterD44
TUPED706 Clinic-level factors influencing the decision to adopt trauma-informed care in HIV primary care settingsE-posterD44
TUPED707 Caregivers' representations of and attitude towards people living with HIV/AIDSE-posterD44
TUPED708 Moral barriers for HIV/AIDS prevention and care among men who have sex with men: Challenges in times of conservatism in BrazilE-posterD44
TUPED709 Police occupational health as an element of HIV risk environment: Factors predicting needle stick injury in the line of dutyE-posterD46
TUPED710 The cost-effectiveness of evidence-based HIV testing interventions in six US citiesE-posterD47
TUPED711 Expanded access to patient-level TB/HIV (big) data opens doors to enhance data utilization and improve data qualityE-posterD48
TUPED712 Quality improvement approach to influence quality health care services for children and adolescents in wakiso district health facilitiesE-posterD48
TUPED713 Harmonizing community prevention data in the National Prevention Database (NPD) system in CambodiaE-posterD49
TUPED714 Data actualization: A methodology to periodically monitor and update the reported number of patients active on ARTE-posterD50
TUPED715 Determining the utilization of the electronic patient management system (EPMS) for patient management and care - an implementation fidelity approach to strengthening health systemsE-posterD50
TUPED716 Impact of eHealth platforms and enhanced surveillance in strengthening, evaluating and improving performance in HIV programs: Evidence from the Zambian EQUIP programE-posterD50
TUPED717 Improving data collection processes and reporting efficiencies in large HIV programsE-posterD50
TUPED719 Moving from 'it's impossible' to possible: Using REDCap to successfully manage studies using the multiphase optimization strategy (MOST) and other multicomponent intervention studiesE-posterD52
TUPED721 'The woman gives': Exploring gender and relationship factors in HIV advance care planning among African American caregiversE-posterD53
TUPED722 HIV prevention decisions by at-risk young women in South Africa: Proposing a novel Integrated behavioral journey framework using a mixed methods research approachE-posterD53
TUPED724 'Either you float or you drown:' Social ties, stigma, and lived experiences of the HIV care continuum in HPTN 065E-posterD54
TUPED725 The acceptability of Combined Community Engagement Strategies Study (ACCESS): Results of a novel pilot for extending community feedback on HIV clinical trialsE-posterD56
TUPED726 Community engagement in HIV key populations hotspots mapping and size estimation in NigeriaE-posterD56
TUPED727 Young MSM and heterosexual men's high acceptability of long-acting implants and injections for HIV prevention in South Africa: Results of a discrete-choice experimentE-posterD57
TUPED728 Mental health and retention in HIV services among adults initiating antiretroviral therapy in TanzaniaE-posterD59
TUPED729 Mental health outcomes of an intervention to improve ART adherence among MSM living with HIV in MexicoE-posterD59
TUPED730 Influence of stigma and discrimination on psychosocial health in children affected by AIDS in Nepal: A cross-sectional studyE-posterD59
TUPED731 How youth living with HIV in Uganda experience stigma: Results of a photovoice studyE-posterD59
TUPED732 Experienced stigma, mental health, and life outlook: Select data from a quality of life survey of PLHIV in five fast-track citiesE-posterD59
TUPED733 Psychosocial variables related to serostatus disclosure to couples in Mexican people with HIVE-posterD60
TUPED734 Real lived experiences of being LGBTI and HIV positiveE-posterD60
TUPED735 “Not a walking piece of meat with disease”: Undetectability and quality of life among HIV-positive gay, bisexual and other men who have sex with men in the U=U eraE-posterD61
TUPED736 A grounded theory of HIV-Stig H ma among youth living with IV in Western UgandaE-posterD62
TUPED737 “We should choose or decide. You know, we're the ones that are here”: Selecting community-based research priorities in aging with HIVE-posterD63
TUPED738 Ageing of HIV epidemic in India: Insights from HIV estimation modelling under National AIDS Control ProgrammeE-posterD63
TUPED739 Loneliness among older people living with HIV: Why the “older old” are less lonely than the “younger old”E-posterD63
TUPED740 “There's no retirement plans for us”: Re-analysis from a qualitative study of HIV-positive MSM who use substancesE-posterD63
TUPED741 “Communication, compatibility, compromise, and commitment…we allow ourselves the room to grow and change”: Qualitative findings from Canadian gay, bisexual and men who have sex with men in current HIV-serodifferent relationshipsE-posterD64
TUPED742 I want to be like you: A case study of individual and group peer counseling for women in MexicoE-posterD64
TUPED743 The next generation: Pregnancy outcomes in adolescents and women living with perinatally acquired HIV in South AfricaE-posterD65
TUPED744 Are we covered? Family planning uptake and needs among women on ART in ZimbabweE-posterD65
TUPED745 Reasons for contraceptive discontinuation among HIV-infected Ugandan women on depo-provera and tenofovir-based ARTE-posterD65
TUPED746 Adolescent hormonal contraception use and childbearing ideation in the era of HIV - Findings from a large community-based study in South AfricaE-posterD65
TUPED747 High daily tobacco smoking participation among Australian HIV-positive gay and bisexual menE-posterD67
TUPED748 Cognitive functioning and driving ability in HIV-infected professional driversE-posterD67
TUPED749 HIV-infected women: Medical co-morbidities and rates of virologic suppressionE-posterD67
TUPED750 Acceptability of a smartphone-based music intervention for chronic pain and problematic opioid use among patients living with HIVE-posterD68
TUPED751 HIV struggles: Conceptualizing human rights (HR) and how to implement themE-posterD70
TUPED752 Temporal trends in HIV-related self-reported stigma in the African Cohort Study, 2013-2018E-posterD70
TUPED753 Educational attainment and HIV risk among young adults, Rakai, Uganda 1996 - 2013E-posterD70
TUPED754 Social capital needs of young Black gay, bisexual and other men who have sex with men living with HIV in Atlanta, USAE-posterD70
TUPED755 The social-structural syndemic in Nepal: Cross-border movement, incarceration, and poor access to harm reduction programs fuel the HIV and hepatitis C epidemic among people who inject drugsE-posterD70
TUPED756 Correlates of antiretroviral adherence among people living with HIV engaged in peer-to-peer HIV counseling in MyanmarE-posterD70
TUPED757 Assessing perceived impacts of climate change on HIV health among HIV-infected smallholder farmers in the Nyanza region of KenyaE-posterD70
TUPED758 Divergent preferences for HIV testing services among young people in Nigeria: A choice experimentE-posterD70
TUPED759 HIV-related stigma, neighborhood poverty, and viral load suppression among men who have sex with men in Atlanta, Georgia, USAE-posterD70
TUPED760 What about housing? Understanding a constant hurdle for Latinx PLWH in San Francisco, CAE-posterD70
TUPED761 Social vulnerability, syndemics and the continuum of HIV care among people living with HIV/AIDS in BrazilE-posterD71
TUPED762 High levels of social and structural adversity among disabled HIV-positive adult caregivers of young people living with HIV: Implications for HIV programmingE-posterD72
TUPED763 Characteristics of intersectional stigma and effects on HIV testing uptake among Black MSM in the United StatesE-posterD72
TUPED764 Who are the men who pay for sex in Mozambique? Results from the National HIV/AIDS Indicator Survey (IMASIDA) 2015E-posterD74
TUPED765 Mediators of the relationship between transactional sex and incident HIV infection among young women in South Africa enrolled in HPTN 068E-posterD74
TUPED766 Being young and on the move in sub-Saharan Africa: How 'waithood' exacerbates HIV risks and disrupts the success of current HIV prevention interventionsE-posterD75
TUPED767 High HIV positive yield among clients of female sex workers in the context of socio-political unrest in Bamenda, CameroonE-posterD76
TUPED768 The end is still too far: Human rights violations among people living with HIV and AIDS enrolled in a semi-urban health center in KenyaE-posterD76
TUPED769 Childhood and adulthood exposure to violence linked to HIV risk behaviors among men in EswatiniE-posterD76
TUPED770 Characterizing the relationship between violence and HIV infection among sex workers across 10 countries in sub Saharan AfricaE-posterD76
TUPED771 Police abuse, ART adherence, and harm reduction among PWID living with HIV in UkraineE-posterD76
TUPED772 Sexual violence and HIV risk in the bridging population of men who have sex with both men and women: Longitudinal data from four countries of West AfricaE-posterD77
TUPED773 Redressing violence among female sex workers through crisis response system: Experience from a community-led HIV prevention intervention in IndiaE-posterD77
TUPED774 Association between forced sexual initiation, sexual risk behaviours and HIV status among young people in Botswana: A cross-sectional studyE-posterD77
TUPED775 Assessing the risk of incarceration on time to first injection initiation assistance provision among a cohort of people who use drugs in Vancouver, CanadaE-posterD78
WEPEA042 Clonal integration site expansion of infected cells is a main contributor of HIV persistence in more differentiated T cell subsets during suppressive ARTE-posterA19
WEPEA042 Clonal integration site expansion of infected cells is a main contributor of HIV persistence in more differentiated T cell subsets during suppressive ARTE-posterA19
WEPEA043 Galectin-1 promotes HIV-1 latency reactivationE-posterA20
WEPEA044 Cellular modulation and HIV reactivation in response to serial treatment of latently HIV-infected CD4 T cells with Histone Deacetylase inhibitors (HDACi)E-posterA20
WEPEA045 Cell-penetrating inhibitors of the Hsp70 chaperone activity can prevent HIV-1 reactivation from latencyE-posterA20
WEPEA046 Specific characteristics of certain CD4 T cell subsets are related to HIV reservoir sizeE-posterA20
WEPEA047 Two decades of antiretroviral therapy provide no evidence for re-seeding of the HIV DNA reservoir by ongoing viral replicationE-posterA21
WEPEA048 Effector memory cells are the main contributors to the replication-competent HIV reservoir in ART-suppressed individualsE-posterA21
WEPEA049 ICOS is preferentially expressed by productively infected cells in the blood and lymph nodes from HIV-infected individualsE-posterA21
WEPEA050 The CARMA study - children on early suppressive therapy: Total HIV-1 DNA quantitation 12 years post ART initiationE-posterA21
WEPEA052 Kansui, an ingenol-containing herbal supplement, safely induced CD8, NK, and monocyte activation in three ART-suppressed SIVmac251-infected rhesus macaquesE-posterA22
WEPEA053 Large in vivo expansion and subsequent partial contraction of a T cell clone carrying a defective HIV genome reflect the dynamics of the HIV reservoir during ARTE-posterA22
WEPEA054 Viral dynamics during suppressive ART - Towards HIV elimination from reservoirsE-posterA22
WEPEA055 Latency reactivating agents: Impact on human macrophages physiology and susceptibility to HIV-1 infectionE-posterA23
WEPEA056 Discovery and mechanistic study of novel suppressors of post-integrated HIV expression from African natural productsE-posterA23
WEPEA057 Development of Cytotoxic Enhancing Agents (CEAs) to improve shock-and-kill strategiesE-posterA23
WEPEA059 CD8 depletion plus signaling of the non-canonical NF-kB pathway reverses latency in SIV-infected, ART-suppressed rhesus macaquesE-posterA23
WEPEA060 The SMAC mimetic AZD5582 reverses HIV latency as a single agent in resting primary CD4+ T cellsE-posterA23
WEPEA061 Regulation of Cas9 by viral proteins REV and TAT for in vitro inactivation of HIV-1 proviral DNAE-posterA23
WEPEA062 Vedolizumab-mediated integrin α4β7 blockade does not control HIV-1SF162 rebound after cART interruption in humanized miceE-posterA24
WEPEA063 A glycosyl phosphatidylinositol-anchored anti-HIV antibody neutralizes HIV-1 replication in dendritic cell-T cell cocultures through both cis and trans mechanismsE-posterA26
WEPEA064 CRISPR/Cas9 targeting HIV-1 regulatory genes inactivates latent proviral DNA and prevents new infection in T cell culture with inhibition of viral escapeE-posterA26
WEPEA065 Allogeneic stem cell transplant in HIV-1 infected individuals; An update of the IciStem ConsortiumE-posterA26
WEPEA066 Rapamycin immune tolerization enables gene transfer following subcutaneous delivery of AAV6 but not CD4-retargeted AAV6 vectors in AAV-seropositive rhesus macaquesE-posterA26
WEPEA067 HLA B27 and HLA B57 alleles in HIV-infected long term non progressor childrenE-posterA27
WEPEA068 High frequency of activated Treg and Th17 cells in HIV elite controllersE-posterA27
WEPEA069 Breastfeeding and mother-to-child transmission of HIV: Contribution of breast milk miRNAE-posterA28
WEPEA070 Sterol metabolism modulates susceptibility to HIV-1 Infection in HESNsE-posterA28
WEPEA071 Endoplasmic reticulum associated aminopeptidases 2 (ERAP2) is released in the secretome of activated MDM and reduces in vitro HIV-1 infectionE-posterA29
WEPEA100 Oral cART hu-PBMC mouse model to study HIV persistent infectionE-posterA52
WEPEA101 Role of gut microbiota on vaccine response in HIV exposed InfantsE-posterA52
WEPEB279 Highly diverse anaerobe-predominant vaginal microbiota among pregnant women with HIV in ZambiaE-posterB58
WEPEB280 Pregnancy outcomes among HIV-positive women on dolutegravir versus efavirenz-based antiretroviral therapy: Week 48 analysis of the ADVANCE trialE-posterB58
WEPEB281 Impact of isoniazid and pregnancy on efavirenz pharmacokinetics in women living with HIVE-posterB58
WEPEB282 Comparison of adverse birth outcomes among HIV-infected and HIV-uninfected women in the era of universal ART in Malawi: A registry studyE-posterB58
WEPEB283 Vaginal progesterone to prevent preterm delivery among pregnant women with HIV in Zambia: A pilot feasibility studyE-posterB58
WEPEB284 Monitoring and supporting women living with HIV who choose to breastfeed their HIV-exposed infants in BotswanaE-posterB58
WEPEB285 Failure to account for delivery phenotype minimizes the apparent effect of HIV on preterm birthE-posterB58
WEPEB286 Medroxyprogesterone acetate (MPA) exposure and risk of female-to-male HIV transmission among serodiscordant couples in East and southern AfricaE-posterB60
WEPEB287 Examining contraceptive use in an urban Ugandan HIV clinic after the dolutegravir safety alertE-posterB60
WEPEB288 Symptom burden and inflammatory cytokines in persons living with HIV in the US: An analysis by sex and menopause stageE-posterB61
WEPEB289 Assessing gaps in comprehensive HIV and women's health care across a typology of care for women living with HIV in CanadaE-posterB62
WEPEB290 Validation of self-reported combination antiretroviral therapy (cART) regimens in a multi-site Canadian cohort of women living with HIVE-posterB62
WEPEB291 HIV positivity trends among HIV-exposed children tested on point-of-care early infant diagnosis in MozambiqueE-posterB63
WEPEB292 Analysis to change public health strategy in the diagnosis investigation of children exposed to HIV in BrazilE-posterB63
WEPEB293 Innovations in index case contact testing to improve the identification of HIV-infected children and adolescentsE-posterB63
WEPEB294 Virological suppression in children after switch to a Raltegravir-containing regime in Brazil: A real life studyE-posterB67
WEPEB295 The youth peer mentor role in supporting adolescent HIV care: A qualitative studyE-posterB67
WEPEB296 Providing childhood TB care in a high prevalence HIV/TB setting: The experience of Baylor College of Medicine in EswatiniE-posterB67
WEPEB298 Pediatric anti-retroviral therapy (ART) and care of HIV-infected children in Myanmar: Gaps and challengesE-posterB67
WEPEB299 Time to viral load suppression and rebound among Canadian infants and children initiating cART in the Early Pediatric Initiation Canada Child Cure Cohort (EPIC4) StudyE-posterB67
WEPEB300 Children's perceptions of HIV cure research: An end of study assessment of the Early Pediatric Initiation, Canada Child Cure Cohort (EPIC4) studyE-posterB68
WEPEB301 Outcomes of children and adolescents living with HIV considered lost to follow up at IeDEA-SA cohorts in the Western Cape: Linkage to Western Cape Provincial Health Data Centre recordsE-posterB69
WEPEB302 Twelve-month outcomes among paediatric and adolescent patients initiated on ART from 2007 to 2016 in Nigeria: A retrospective cohort studyE-posterB69
WEPEB304 In utero/early life anti-retroviral exposure related changes in socioemotional adjustment indices by 6-10 years of life in HIV exposed Ugandan childrenE-posterB73
WEPEB305 Mental health and its association with metabolic outcomes in youth living with perinatally acquired HIV in the Cape Town Adolescent Antiretroviral Cohort (CTAAC)E-posterB73
WEPEB306 Developmental defects of enamel in primary dentition after in utero TDF exposureE-posterB74
WEPEB307 Patient characteristics associated with viral suppression do not predict patient confidence in the healthcare transition process among youth living with HIVE-posterB75
WEPEB308 Perinatally HIV-infected adolescents transition to adult care: A natural experimentE-posterB75
WEPEB310 High incidence of syphilis in transgender women in Buenos Aires, ArgentinaE-posterB79
WEPEB311 Transgender-led same-day antiretroviral therapy services at the Tangerine Community Health Center in Bangkok, ThailandE-posterB79
WEPEB312 Prevalence and consequences of gender affirmation procedures done outside of medical care among transwomen in São Paulo, BrazilE-posterB79
WEPEB313 Predictors of increased carotid intimal media thickness among transgender women: A cross-sectional studyE-posterB79
WEPEB314 Risk of polypharmacy and inappropriate prescribing in persons living with HIV ≥ 65 years of ageE-posterB82
WEPEB315 Improved HIV care in incarcerated individuals via telemedicine in Pennsylvania, United StatesE-posterB82
WEPEC494 Provision of residual drug level results from the dapivirine ring open label extension study: Participant reactions and explanations during a qualitative ancillary study (MTN 032)E-posterC46
WEPEC495 HIV pre-exposure prophylaxis (PrEP) dosing preference and reported use in the EPIC-NSW trialE-posterC46
WEPEC496 HIV prevention in men who have sex with men as inferred from their adherence to daily versus event-driven pre-exposure prophylaxis: Cross-over clinical trialE-posterC46
WEPEC497 A self-administered scale for assessing adherence of men who have sex with men to pre-exposure prophylaxisE-posterC46
WEPEC498 Prevalence of HIV testing, unrecognized HIV infection and ART uptake among key population in India: Findings from a large-scale multi-centric cross-sectional surveillance surveyE-posterC46
WEPEC499 Role of support groups in promoting pre exposure prophylaxis (PREP) adherence among men who have sex with men (MSM) in Hoymas Clinic Nairobi, KenyaE-posterC46
WEPEC500 Effect of DREAMS interventions on HIV risk among out-of-school adolescent girls and young women (AGYW) with higher and lower HIV vulnerability: Results from MalawiE-posterC47
WEPEC501 Using the one stop shop (OSS) based point of service (POS) strategy for effective prevention, care and treatment to key populations (KP) in Nasarawa State, NigeriaE-posterC47
WEPEC502 Sexual behaviour and perceived HIV risk among HIV-negative members of serodiscordant couplesE-posterC48
WEPEC503 The syndemic of alcohol/drug use and violence victimisation and its effects on HIV transmission risk among transgender women: Cross-sectional, population-based study in IndiaE-posterC49
WEPEC504 Depression among HIV-positive female sex workers in Malawi is associated with prior treatment default, experience of violence, and low incomeE-posterC49
WEPEC505 Understanding high-risk injection practices among people who inject drugs following the closure of a rural syringe services programE-posterC53
WEPEC506 Evaluating impact of harm reduction on the HIV epidemic among people who inject drugs in ChinaE-posterC53
WEPEC507 Comparative analysis of effectiveness of HIV testing modalities among PWID in UkraineE-posterC53
WEPEC508 Characteristics of buprenorphine injecting drug abuser in Bandung; a cross-sectional studyE-posterC53
WEPEC509 Heroin use and sexual risk behaviours among HIV/HCV co-infected methadone patients in MyanmarE-posterC53
WEPEC510 Using a multiple approach to increase uptake of HIV testing services among adolescent girls and young women: TASO MbararaE-posterC54
WEPEC511 Engaging adolescent girls and young women in HPTN 082: Lessons learnedE-posterC54
WEPEC512 HIV testing and treatment among adolescents and young people in a high burden district with annual home-based HIV testing: Findings from the Chókwè Health Demographic Surveillance System (CHDSS), Mozambique, 2014-2017E-posterC54
WEPEC513 Risky sexual behavior among in-school adolescents participating in the Girls Achieve Power Trial in South Africa: Intervention considerations for high HIV prevalence settingsE-posterC54
WEPEC514 Shifts in HIV-risk outcomes among adolescent girls and young women (AGYW) in KenyaE-posterC54
WEPEC515 Empowering adolescent girls and young women to remain HIV-free: Outcomes of a DREAMS HIV self-testing and PrEP combination prevention intervention targeting AGYW and male partnersE-posterC54
WEPEC516 Impact of a community-level combination HIV prevention intervention on knowledge of HIV status amongst adolescents: Primary results of HPTN 071 (PopART) for Youth StudyE-posterC54
WEPEC517 Getting to first 90: Factors associated with ever being tested for HIV among transgender women, intersex, and Hijras who have sex with men reached online in India: Implications for interventionE-posterC55
WEPEC518 Developing a model to prioritise male-to-female transgendered people/Hijras for differentiated prevention services in targeted interventions in IndiaE-posterC55
WEPEC519 Factors associated with condom use with non-commercial partners among transgender women in Cambodia: Findings from a national survey using respondent-driven samplingE-posterC55
WEPEC520 Combined mobile and static clinic approach to increase HIV testing and positive yield for transgender population in Lahore, PakistanE-posterC55
WEPEC521 Low PrEP uptake but good retention among transgender women: Preliminary results from real-world PrEP roll-out in VietnamE-posterC55
WEPEC522 Why intervention among migrants is required for enhancing HIV/AIDS prevention responses in India? A study of National AIDS Control ProgrammeE-posterC56
WEPEC523 Sustaining safe sex behavior among female sex workers by addressing their vulnerabilities and strengthening community-led organizations in IndiaE-posterC57
WEPEC524 Unintended HIV prevention outcomes of a cash transfer trial on child development in East Zimbabwe: Evidence from a cluster-randomised trial and general-population surveyE-posterC57
WEPEC525 Achieving the first two 90s of 90-90-90 target of female sex workers: Impact of peer educators' model in MalawiE-posterC57
WEPEC526 Barriers and facilitators of uptake of minimum prevention package intervention (MPPI) by men who have sex with men (MSM) in NigeriaE-posterC57
WEPEC527 Updating national guidelines to scale up PrEP implementation: The Taiwan experienceE-posterC60
WEPED776 Predictors of anticipated healthcare stigma among adult men who have sex with men in the United States and across sub-Saharan African countriesE-posterD81
WEPED777 Use of enhanced peer mobilizers to increase MSM reach for HIV clinical services in ZimbabweE-posterD81
WEPED778 Condomless intercourse with female partners among bisexual male sex workers in the Dominican Republic: A social network analysisE-posterD81
WEPED779 Depressive symptoms and substance use: Changes overtime among a cohort of HIV-positive and HIV-negative MSME-posterD81
WEPED780 Depressive symptoms as a predictor of HIV seroconversion among young adult African-American/Black men and transgender women who have sex with men in the Southeastern United StatesE-posterD81
WEPED781 HIV care cascade in men who have sex with other men in Paraguay 2017: Combination of epidemiological surveillance data studies with laboratory dataE-posterD81
WEPED782 Understanding low rates of HIV testing among men in Colombia: Findings from a population-based surveyE-posterD81
WEPED783 Low viral suppression among HIV-positive men who have sex with men in Mpumalanga, South AfricaE-posterD81
WEPED784 HIV testing by MSM peer educators: High HIV-positive yield among MSM living in Yaoundé tested by Humanity First CameroonE-posterD81
WEPED785 Assessing sexual event-level substance use and risk behavior for HIV infection in a diverse sample of HIV-negative MSM in the era of PrEP, 2018E-posterD81
WEPED786 Perceived barriers to access available HIV and STIs services among men who have sex with men (MSM) in Tanga Region Northern, TanzaniaE-posterD81
WEPED787 Types of group sex and their association with sexual risk behaviors among HIV-negative men who have sex with men (MSM)E-posterD81
WEPED788 Family characteristics in sex communication and social support: Implications for emerging adult men who have sex with men's PrEP engagementE-posterD81
WEPED789 Identifying the experiences of young gay, bisexual, and other men who have sex with men who engage in the sexualized use of cannabisE-posterD81
WEPED790 “It's easy and convenient!”: Perceived facilitators and barriers for HIV self-testing and PrEP uptake among adolescent men who have sex with men, transgender women and their parentsE-posterD81
WEPED791 High sexual risk behaviours as a determinant to HIV infection among MSM in NigeriaE-posterD81
WEPED792 Risk correlations of intimate partner violence among men who have sex with men in Chengdu, ChinaE-posterD81
WEPED793 Perceived barriers to emerging PrEP modalities in the US: Social determinants of health and modality-specific attributes may inhibit PrEP uptake among sexual and gender minority adolescentsE-posterD81
WEPED794 Understanding expressions of masculinity among HIV-positive, adolescent men who have sex with men in Mexico CityE-posterD81
WEPED795 Understanding gay couples: A new vision for HIV prevention in PeruE-posterD81
WEPED796 Testing the Stall et al´s (2008) theory of syndemic production among MSM in India: Cross-sectional studyE-posterD81
WEPED797 Informal pain management after reduction/discontinuation in opioid therapyE-posterD82
WEPED798 Alcohol, drug use and mood disorders in a random sample of HIV positive rural South African menE-posterD82
WEPED799 Urgent need to address multiple high-risk behavior and prevent HIV among young PWIDE-posterD82
WEPED800 Sex work as a mediator between female sex and incident HIV infection among people who inject drugs in Tijuana, MexicoE-posterD82
WEPED801 Increased HIV prevalence and risk among women who inject drugs compared to men who inject drugs in TajikistanE-posterD82
WEPED802 Egocentric network and HIV/HCV risk behaviors among drug users on methadone maintenance treatment in Wuhan, ChinaE-posterD82
WEPED803 The association between opioid agonist treatment and injection initiation assistance among persons with different injection polydrug use practices in Vancouver, CanadaE-posterD82
WEPED804 Estimating and reaching drug users with HIV prevention package in MaliE-posterD82
WEPED805 Understanding the public health consequences of closing a rural syringe services program in Charleston, West Virginia (USA)E-posterD82
WEPED806 Injection drug use association with HIV and sex work stigma in Kenyan sex workersE-posterD82
WEPED807 HIV, housing, and health: A case study of the experiences of people living with HIV who use drugs living in two models of supportive housing in Vancouver, CanadaE-posterD82
WEPED808 A qualitative investigation of HIV treatment dispensing models and impacts on adherence among people living with HIV who use drugs and live in low-income housingE-posterD82
WEPED809 Community initiated treatment for HIV-positive people who inject drugs in UkraineE-posterD82
WEPED810 The syndemic of violence victimisation, incarceration, risky injecting behaviours and HIV infection among people who inject drugs: Cross-sectional, population-based study in IndiaE-posterD82
WEPED811 Enabling factors for rapid scale-up of services for sex workers in large urban African sites, 2014-2018E-posterD83
WEPED812 Viral load monitoring among FSWs enrolled in the LINKAGES project in Malawi: Progress, challenges, and opportunitiesE-posterD83
WEPED813 Why not PrEP? Evaluation of PrEP refusal and discontinuation among transgender women in PeruE-posterD84
WEPED814 Reduction of anxiety, drug and alcohol abuse and increment of quality of life in transgender women after 6 months of initiating HIV treatmentE-posterD84
WEPED815 "Papi, I take care of myself and take care of you": PrEP communication and disclosure among Latina immigrant transgender women in the Washington DC metropolitan areaE-posterD84
WEPED816 Burden of PTSD, depression, and anxiety on transgender HIV+ and HIV- persons at key population-led health centers in Bangkok and Pattaya: Mixed methods cross-sectional screening studyE-posterD84
WEPED817 "I was just concerned about getting pregnancy": Reproductive health decision making among adolescent girls in Thika, KenyaE-posterD85
WEPED818 Preventing HIV in adolescent girls and young women: Presentation of Lesotho qualitative resultsE-posterD85
WEPED819 High levels of gender-based violence (GBV) among HIV-positive adolescent girls and young women (AGYW) at antenatal clinics in Malawi highlights need for GBV servicesE-posterD85
WEPED820 Factors associated with HIV seropositivity among male sexual partners of adolescent girls and young women (AGYW) in Tanzania: Findings from a combination prevention programE-posterD85
WEPED821 Adolescent girls on PrEP: Findings from Kenya's oral PrEP scale-up supported by JilindeE-posterD85
WEPED822 Motivations for early PrEP discontinuation among Kenyan adolescent girls and young women: A qualitative analysis from a PrEP implementation programE-posterD85
WEPED823 Progress towards the UNAIDS 1st 90: A descriptive assessment of pregnant adolescent girls & young women attending antenatal care clinics in 24 districts in Zimbabwe (2017- 2018)E-posterD85
WEPED824 Understanding the vulnerabilities of adolescent girls and young women in Oshikoto region, NamibiaE-posterD85
WEPED825 The effectiveness of the DREAMS eligibility screening: How do we know if we are reaching vulnerable adolescent girls and young women (AGYW) aged 10 - 24? Namibia, 2018E-posterD85
WEPED826 Migrant patients living with HIV/AIDS in Japan: Review of factors associated with high dropout rate in a leading medical institution in Japan: Second reportE-posterD86
WEPED827 “The doctor told me straight up that 'we hate you'”: Foreign migrant adolescent girls' and young women's access to sexual and reproductive health services in South AfricaE-posterD86
WEPED828 HIV prevention cascade awareness and engagement among urban refugee and displaced adolescents and youth in Kampala, UgandaE-posterD86
WEPED830 Understanding the social structural production of HIV risk among a population of marginalized Latina young women: Prevention efforts among changing risk environmentsE-posterD88
WEPED832 Factors associated with condom use by men in extra marital relationships in BeninE-posterD88
WEPED833 "AIDS is our greatest enemy!" A pilot study on a cultural sensitive approach to HIV prevention among Yi (Nuosu) ethnic minority group in Southwest ChinaE-posterD88
WEPED834 Sociodemographic characteristics and sexual behaviours among HIV positive and HIV negative adolescents in a primary care setting in Mexico: A case control studyE-posterD88
WEPED835 Multisite qualitative evaluation of microbicide/PrEP acceptability among mothers and male partners in Africa: The MAMMA studyE-posterD88
WEPED836 Piloting early detection of HIV, tuberculosis and hepatitis C in probation settings in UkraineE-posterD88
WEPED837 Associations between mental and substance use disorders and virologic failure among adolescents attending antiretroviral therapy clinics in South Africa and ZimbabweE-posterD88
WEPED838 High risk men utilize traditional healers instead of biomedical facilities in southwestern Uganda: Results from a mixed methods studyE-posterD88
WEPED839 HIV prevention among young key population: Community-based strategy outcomes, BrazilE-posterD88
WEPED840 "HIV is much better than diabetes, with HIV you take your pill and that's it!": A qualitative study in three South African provincesE-posterD88
WEPED841 The hardest thing is to return to who I was before the diagnosis”: Gendered stigma among naïve older patients presenting to HIV care in UkraineE-posterD88
WEPED842 Understanding of perceived infectiousness and its influence on sexual behavior among individuals with acute HIV infection in Lilongwe, Malawi (HPTN 062)E-posterD89
WEPED843 Enhance peer outreach approached help to penetrate the “Gharana” system and identify new case detection among Hijra (Transgender) in Mumbai, IndiaE-posterD89
WEPED844 Willingness to pay for PrEP within high HIV burden counties in Kenya: Results from a population-based surveyE-posterD89
WEPED845 Factors associated with perceived and current HIV risk among men who have sex with men in Brazil, Mexico and PeruE-posterD89
WEPED846 Assessment of the change in sexual and health seeking behaviour of men who have sex with men (MSM) and Transgender/Hijra (TG/H) populationE-posterD89
WEPED847 Effectiveness of quality improvement on occurrence of needle stick injuries in Harare City, Zimbabwe, 2017: A quasi-experimental studyE-posterD89
WEPED848 How will eventual HIV cure impact prevention behavior?E-posterD89
WEPED849 Perceptions of HIV risk and knowledge of HIV prevention strategies among young minorities recently diagnosed with HIV infection in South Texas, Unites States (U.S.)E-posterD89
WEPED850 HIV prevention knowledge gaps on pre-exposure prophylaxis (PrEP) among adolescents and young people aged 15-24: Insights from formative research in two urban communities in Lusaka, ZambiaE-posterD89
WEPED851 What we know and don't know about adolescent girls and young women and HIV Prevention in sub-Saharan Africa: Analysis of insights across completed, ongoing and planned projectsE-posterD89
WEPED852 Differences in ART provider expectations and client knowledge about viral load testing in northern Namibia: A qualitative assessmentE-posterD90
WEPED853 Community ART centres - are they filling the gap and meeting the grade? A comparison of quality and numbers between community-based ART centres and conventional hospitals in ZambiaE-posterD90
WEPED854 HIV provider and vocational driver knowledge of HAND and needs for health managementE-posterD90
WEPED855 Occupation and education among youth living with HIV receiving care at two tertiary care hospitals in Bangkok, 2017E-posterD90
WEPED856 Strategic donor investments for strengthening condom markets: The case of ZimbabweE-posterD93
WEPED857 Traditional beliefs on gender roles and HIV risk behaviour among adult men interested in voluntary medical male circumcision, South AfricaE-posterD94
WEPED858 Acceptability of voluntary medical male circumcision in Zambia: Using population-level data to inform demand-creation strategiesE-posterD94
WEPED859 The power of habits for sustained high ART adherence and the use of incentives for building themE-posterD95
WEPED860 Profile of self-reported adherence to HIV pre‑exposure prophylaxis in BrazilE-posterD96
WEPED861 Scaling-up PrEP offer in the Brazilian Unified Health System (SUS)E-posterD96
WEPED862 Women's perceived barriers and facilitators towards long-acting injectable pre-exposure prophylaxis (PrEP): Results from six cities across the United StatesE-posterD96
WEPED863 Willingness to screen for pre-exposure prophylaxis in pharmacies among men who have sex with menE-posterD96
WEPED864 Acceptability of and preferences for novel HIV pre-exposure prophylaxis (PrEP) delivery methods among sexual and gender minority (SGM) adolescents assigned male at birth in the USAE-posterD96
WEPED865 Advancing HIV prevention through public opinion polling: Lessons from the southern United StatesE-posterD96
WEPED866 The negative direct effect of depressive symptoms on PrEP adherence among high-risk South African women In HPTN 067E-posterD96
WEPED867 High and sustained use of a gamified PrEP adherence app (P3: Prepared, Protected, emPowered) among young MSME-posterD96
WEPED868 Multilevel approach in optimizing assisted partner notification services (aPNS): A case study at Awendo Sub County Hospital, Western Kenya; January to August 2018E-posterD90
WEPED869 Knowledge about pre-exposure prophylaxis (PrEP) among sexual and gender minority (SGM) adolescents assigned male at birth in the United States (US)E-posterD96
WEPED870 Scale-up of pre-exposure prophylaxis through reorientation of health services in eight districts in Northern NamibiaE-posterD96
WEPED871 Sexual behavior changes, PrEP and condom use in the ANRS Prevenir studyE-posterD96
WEPED872 Factors associated with adherence to HIV post-exposure prophylaxis among survivors of sexual assault in the Bojanala District, North West, South AfricaE-posterD97
WEPED873 Final HIV outcome for exposed infants: Improving mother-baby pair retention in prevention of mother-to-child transmission care in Eswatini through proactive community follow-upE-posterD101
WEPED874 Improving adolescent sexual and reproductive health through participatory parent-child communication interventions in rural communities of Eastern UgandaE-posterD101
WEPED875 Reducing vulnerability to TB co-infection and morbidity of opportunistic infections from biomass fuel-household air pollution amongst positive women & children in rural households in Kisumu CountyE-posterD101
WEPED876 A qualitative evaluation of the ACCELERATE! initiative: HIV prevention, care and treatment Interventions for Black men who have sex with menE-posterD101
WEPED877 Perceptions of ART outreach services in the community among stable and expert HIV-positive clients: A qualitative focus group discussion from TanzaniaE-posterD101
WEPED878 Reaching the third 90: Differentiated treatment options involving village health workers in rural ZimbabweE-posterD101
WEPED879 Impact of a community-based antiretroviral therapy (ART) delivery program for female sex workers (FSWs) in Tanzania - Results of a quasi-experimental studyE-posterD101
WEPED880 Long term impact assessment of programme titled Pehchan: “Strengthen community institutions and systems for MSM, Hijra and transgender communities to increase reach and quality of services”E-posterD101
WEPED881 Role of WhatsApp in empowering female sex workers in India: Learnings from large scale community-based intervention program in IndiaE-posterD101
WEPED882 Champion community centers: A Philippine model for strengthening and scaling up community-based HIV servicesE-posterD101
WEPED883 HIV and sexual health education: An inner city community-based projectE-posterD101
WEPED884 The ENABLE model: A community-based approach to eliminate mother-to-child transmission of HIV (eMTCT) in rural Eastern Cape, South AfricaE-posterD101
WEPED885 Advocates in action: Peer supporters driving change on the frontlines of service deliveryE-posterD102
WEPED886 A qualitative analysis of the link between violence against women and quality of HIV programming in 8 African CountriesE-posterD102
WEPED887 Holistic demand creation and community mobilisation for PrEP integration into comprehensive sexual reproductive and health (SRH) services for adolescent girls and young women (AGYW) supporting South African National PrEP programmeE-posterD103
WEPED888 Finding the men that matter most: Creating demand for HIV prevention services among very high-risk men in ZambiaE-posterD103
WEPED889 Using knowledge exchange platforms with quality improvement (QI) approaches in the Partnership of HIV-Free Survival to improve prevention of mother to child transmission (PMTCT) of HIV services in sub-Saharan AfricaE-posterD105
WEPED890 Mother-to-child transmission of HIV: A racial phenomenon in BrazilE-posterD105
WEPED891 Too little, too late: Early lessons on Maternal MTCT risk from HIV positive infant case investigation in ZimbabweE-posterD105
WEPED892 Routine evidence for informing eMTCT: Early lessons from case-based investigation of newly diagnosed infants 0-24 months in ZimbabweE-posterD105
WEPED893 Predictors of HIV-exposed infant feeding knowledge and counseling practices among health workers´ in a tertiary center in Northern NigeriaE-posterD105
WEPED894 Using financial diaries to understand the economic lives of women enrolled in PMTCT in Zomba, MalawiE-posterD105
WEPED895 Exploring the conceptual pathways linking savings group participation to medication adherence in MozambiqueE-posterD106
WEPED896 Preferences for conditional economic incentives to improve adherence to pre-exposure prophylaxis: A discrete choice experiment in Mexico CityE-posterD106
WEPED897 Cost of cash transfer programs applied to HIV: A systematic reviewE-posterD106
WEPED898 Stigma, trauma, HIV risk: The closure of a rural syringe services program in West Virginia (USA)E-posterD110
WEPED900 Civil unrest and late entry into HIV care and impact on HIV-related mortality, Juba Teaching Hospital, South Sudan 2013 - 2018E-posterD112
WEPED901 Challenges in access and quality of care for HCV in Ukrainian women's prisonsE-posterD112
WEPED902 Mental health systematic evaluation in newly enrolled adults into a third-care level HIV clinic in Mexico City reveals a very high frequency of mental health care needsE-posterD112
MOPEA025 Alteration of inflammatory cytokine levels in gut, despite its systemic normalization with ART in HIV+ patientsE-Poster BU Poster exhibitionA10
MOPEA029 Fecal exosomes differentially influence translocating bacterial taxa after SIV infectionE-Poster BU Poster exhibitionA12
MOPEB132 Use of undetectable viral load to improve estimates of prior HIV diagnosis and antiretroviral treatment coverage among people living with HIV in population-based surveysE-Poster BU Poster exhibitionB10
MOPEB138 Can genotyping after second-line ART failure reduce the need for DRV/r-based third-line ART in Kenya?E-Poster BU Poster exhibitionB12
MOPEB253 Archived HIV drug resistance in naïve, suppressed and non-suppressed Indian patientsE-Poster BU Poster exhibitionB44
MOPEB254 Integrase strand transfer inhibitor (INSTI) transmitted drug resistance in the Philippines: Implications for the coming shift to first-line INSTI-based antiretroviral therapyE-Poster BU Poster exhibitionB44
TUPEC420 Service provider insights: Implications for national training and support for PrEP provision in South AfricaE-Poster BU Poster exhibitionC27
TUPEC423 Health care providers' self-efficacy at providing oral pre-exposure prophylaxis (PrEP) in Kenya: Results from a cross-sectional surveyE-Poster BU Poster exhibitionC27
TUPEC462 Incidence of sexually transmitted infections among Men who have sex with men in West Africa (CohMSM ANRS 12324-Expertise FrancemE-Poster BU Poster exhibitionC35
TUPEC479 Association between contraceptive use and PrEP uptake and continuation in adolescent girls and young women in Cape Town, South AfricaE-Poster BU Poster exhibitionC38
TUPEC492 Population size estimation of men who have sex with men using online social network multiplier methodE-Poster BU Poster exhibitionC44
TUPED647 Community-based case finding for tuberculosis & HIV integrated with non-communicable diseases in KwaZulu-Natal, South AfricaE-Poster BU Poster exhibitionD21
TUPED718 Factors influencing self-perceived threat of HIV and other STI acquisition and decision-making around voluntary testing among gay, bisexual and other men who have sex with men: A conceptual frameworkE-Poster BU Poster exhibitionD51
TUPED720 Use of 'Design Thinking' tools to enhance the design process of user-centered interventions focused on HIV: A comparative case studyE-Poster BU Poster exhibitionD52
WEPEA041 In-depth transcription profile comparison of multiple primary cell HIV latency modelsE-Poster BU Poster exhibitionA19
WEPEA051 Variable overlap in HIV-1 env sequences obtained from plasma virus after analytical treatment interruption and viral outgrowth assayE-Poster BU Poster exhibitionA22
WEPEA058 Human endogenous retrovirus expression landscape in models of HIV-1 latencyE-Poster BU Poster exhibitionA23
WEPED829 Transnationally-tailored interventions improve retention in HIV care and viral suppression among Latino immigrants living in the Continental U.SE-Poster BU Poster exhibitionD86
MOAB0101 Virologic efficacy of raltegravir vs. efavirenz-based antiretroviral treatment in HIV1-infected adults with tuberculosis: W48 results of the ANRS 12300 Reflate TB2 trialOral abstract session with live Q&AB38
MOAB0102 Week 96 safety and efficacy of the novel HIV-1 attachment inhibitor prodrug fostemsavir in heavily treatment-experienced participants infected with multi-drug resistant HIV-1 (BRIGHTE study)Oral abstract session with live Q&AB39
MOAB0103 Patient views on long acting HIV treatment: Cabotegravir + rilpivirine as maintenance therapy (ATLAS 48 week results)Oral abstract session with live Q&AB45
MOAB0104 Virologic failure In ART-naive HIV patients with high pre-therapy viral load burden initiating on common core agentsOral abstract session with live Q&AB40
MOAB0105 Switching to a single-tablet regimen bictegravir, emtricitabine, and tenofovir alafenamide (B/F/TAF) from dolutegravir (DTG) plus emtricitabine and either tenofovir alafenamide or tenofovir disoproxil fumarate (F/TAF or F/TDF)Oral abstract session with live Q&AB41
MOAB0106 Longer-term (96-week) efficacy and safety of switching to bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF) in womenOral abstract session with live Q&AB41
MOAB0201 Impact of rosuvastatin on atherosclerotic progression in people with HIV at moderate cardiovascular risk; A multinational, randomized, double blind, placebo-controlled trialOral abstract session with live Q&AB27
MOAB0202 History of pulmonary opportunistic infection makes no attributable difference to long-term pulmonary function of people living with HIV who smokeOral abstract session with live Q&AB34
MOAB0203 Validation of serological biomarkers for detection of non-alcoholic fatty liver disease (NAFLD) and/or advanced liver fibrosis in people living with HIVOral abstract session with live Q&AB31
MOAB0204 Assessment of risk factors for hepatocellular carcinoma in HIV care and treatment programs across 31 countries: A cross-sectional surveyOral abstract session with live Q&AB13
MOAB0205 Renal function trajectories after switching from TDF to TAF: A nationwide cohort studyOral abstract session with live Q&AB29
MOAB0206 Gastrocnemius muscle thickness as a predictor of sarcopenia in people living with HIVOral abstract session with live Q&AB32
MOAC0101 Consumption of recreational drugs and their sexualized use in gay men, bisexual and other men-who-have-sex-with-men from Latin America: Preliminary results of the Latin America MSM Internet Survey (LAMIS)Oral abstract session with live Q&AC49
MOAC0102 Polydrug use and HIV sexual risks in a sample of men who inject drugs on the U.S.-Mexico borderOral abstract session with live Q&AC53
MOAC0103 Still left behind: Using programmatic data to assess harm reduction service coverage and HIV treatment cascades for people who inject drugs in five South African citiesOral abstract session with live Q&AC53
MOAC0104 High levels of depression among Peruvian men who have sex with men: Implications for HIV prevention and treatment careOral abstract session with live Q&AD59
MOAC0105 Gender differences in syringe-related policing behaviors and attitudes following a police education program in Tijuana, Mexico: A longitudinal mixed methods analysisOral abstract session with live Q&AD82
MOAD0101 Policing as a structural determinant of HIV risk among people who inject drugs: A systematic literature reviewOral abstract session with live Q&AD82
MOAD0102 Witch-hunt in Brazil: Bill 198/2015, criminalization of HIV transmission and pathologization of dissident sexualitiesOral abstract session with live Q&AD79
MOAD0103 Utilizing individual level data to characterize the relationship between HIV infection and the legal context of sex work across 10 countries in sub Saharan AfricaOral abstract session with live Q&AD79
MOAD0104 A pathway to policy commitment for sustainability of a key population-led health services model in ThailandOral abstract session with live Q&AD34
MOAD0105 Barriers and facilitators to the successful transition of adolescents living with HIV from pediatric to adult care in low and middle-income countries: A policy reviewOral abstract session with live Q&AD62
MOAD0201 Private sector HIV self-testing in Kenya: Insights from a Mystery shopper studyOral abstract session with live Q&AD4
MOAD0202 False negative HIV rapid test results among people living with HIV on antiretroviral therapy in Johannesburg, South Africa: Implications for HIV self-testing roll outOral abstract session with live Q&AD10
MOAD0203 Reaching the unreachable: Early results from index testing in Zambia in the CIRKUITS projectOral abstract session with live Q&AD12
MOAD0204 “Once their wives are OK … they have no disease:"men infer HIV status from partner's results: Qualitative insights into male HIV testing in rural MalawiOral abstract session with live Q&AD51
MOAD0205 Community mobilization is associated with HIV testing, particularly among men and rural dwellers, in ZambiaOral abstract session with live Q&AD58
MOAD0301 PrEP knowledge, intention and uptake among MSM geosocial networking app users in MexicoOral abstract session with live Q&AD96
MOAD0302 Manifestations of stigma in the context of a national oral pre-exposure prophylaxis (PrEP) scale-up program in KenyaOral abstract session with live Q&AD96
MOAD0303 Results from a large Australian PrEP demonstration study: Discontinuation and subsequent HIV and other sexually transmitted infection riskOral abstract session with live Q&AD15
MOAD0304 Predictors of discontinuation in Brazil's free-of-charge PrEP programOral abstract session with live Q&AD96
MOAD0305 A competing risks model for the use of condom in the open-label extension of the ANRS Ipergay studyOral abstract session with live Q&AD96
MOAD0401 Are community-led organizations the drivers for enhancing financial security among female sex workers? Lessons from a large-scale HIV intervention in IndiaOral abstract session with live Q&AD8
MOAD0402 Organizational and individual-level strategies associated with viral suppression in a sample of transgender women receiving care for HIV infection in the U.SOral abstract session with live Q&AD84
MOAD0403 Dreams of an AIDS-free generation: Which supportive factors delay onset of adolescent sexual HIV-risk behaviors in South AfricaOral abstract session with live Q&AD99
MOAD0404 The Sawa Sawa Intervention: A quazi-experimental trial to reduce community level stigma and improve HIV testing service uptake among men in Sofala Province, MozambiqueOral abstract session with live Q&AD109
MOAD0405LB Improving uptake for VMMC in traditional initiation settingsOral abstract session with live Q&AD94
MOAX0101LB HPTN 078: primary results of a randomized study to engage men who have sex with men (MSM) living with HIV who are virally unsuppressed in the USOral abstract session with live Q&AB47
MOAX0102LB Progressive rises in weight and clinical obesity for TAF/FTC/DTG and TDF/FTC/DTG versus TDF/FTC/EFV: ADVANCE and NAMSAL trialsOral abstract session with live Q&AB30
MOAX0103LB Comparison of pregnancy incidence among African women in a randomized trial of intramuscular depot medroxyprogesterone acetate (DMPA-IM), the levonorgestrel (LNG) implant, and the copper intrauterine device (IUD)Oral abstract session with live Q&AB60
MOAX0104LB No occurrences of neural tube defects among 382 women on dolutegravir at pregnancy conception in BrazilOral abstract session with live Q&AB58
MOAX0105LB Neural tube defects by antiretroviral and HIV exposure in the Tsepamo Study, BotswanaOral abstract session with live Q&AB58
MOAX0106LB Addressing the safety signal with dolutegravir use at conception: Additional surveillance data from BotswanaOral abstract session with live Q&AB58
MOSY0105LB Community-led delivery of HIV self-testing targeting adolescents and men in rural Malawi: a cluster-randomised trialOral abstract session with live Q&AD8
TUAA0101 Two-year post-vaccination follow-up from APPROACH: Phase 1/2a randomized study evaluating safety and immunogenicity of prophylactic HIV vaccine regimens combining Ad26.Mos.HIV and gp140 envelope proteinOral abstract session with live Q&AA25
TUAA0102 Protein-supplemented DNA/MVA vaccines: Preclinical immunogenicity and protection for transmitted/founder (B.63521Δ11mutC) and CD4-induced gp120 (rhFLSC) proteinsOral abstract session with live Q&AA40
TUAA0103 A vaccine targeting HIV maturation protects Cynomolgus monkeys against vaginal SIVmac251 acquisitionOral abstract session with live Q&AA40
TUAA0104 A helical structure in the V2 domain of gp120 that localizes to the site of immune pressure in the RV144 vaccine trial is conserved in HIV and SIV envelopesOral abstract session with live Q&AA41
TUAA0105 Lessons from the Research in Viral Eradication of Reservoirs (RIVER) study: Impact of a therapeutic vaccine targeting conserved HIV epitopes on T cell function in treated primary infectionOral abstract session with live Q&AA25
TUAA0201 Preferential infection of α4β7+ CD4+ T cells in early acute HIV-1 infectionOral abstract session with live Q&AA34
TUAA0202 Cellular proliferation maintains genetically intact and defective HIV-1 over timeOral abstract session with live Q&AA21
TUAA0203 Adipose tissue contributes to viral persistence in ART-treated SIV.sab infection in pigtailed macaquesOral abstract session with live Q&AA21
TUAA0204 Selective death induction of HIV-1 infected myeloid reservoirsOral abstract session with live Q&AA23
TUAA0205LB Contribution of naïve CD4+ T cells to the intact HIV reservoirOral abstract session with live Q&AA21
TUAB0101 Periconceptional antiretroviral exposure and central nervous system (CNS) and neural tube birth defects - data from Antiretroviral Pregnancy Registry (APR)Oral abstract session with live Q&AB58
TUAB0102 Adverse pregnancy outcomes among HIV-positive women in the era of universal antiretroviral therapy (ART) remain elevated compared with HIV-negative women in LesothoOral abstract session with live Q&AB58
TUAB0103 Vaginal inflammation is associated with initiating antiretroviral therapy in pregnancy and with spontaneous preterm birthOral abstract session with live Q&AB58
TUAB0104 Characterizing viral load burden among HIV-infected women at time of delivery: Findings from four tertiary obstetric units in Gauteng, South AfricaOral abstract session with live Q&AB58
TUAB0105 Dual epidemics: The impact of HIV and obesity on pregnancy outcomes among women in South AfricaOral abstract session with live Q&AB58
TUAC0101 Transgender people's experiences in HIV testing, sexual partner based violence and mental health in MalawiOral abstract session with live Q&AC55
TUAC0102 Acceptability of HIV and syphilis domiciliary testing among transgender women in Buenos Aires, ArgentinaOral abstract session with live Q&AD84
TUAC0103 Evaluation of syndemics in transgender women using pre-exposure prophylaxis (PrEP) for HIV prevention: Preliminary findingsOral abstract session with live Q&AD84
TUAC0104 Regular consumption of alcohol and risk of HIV infection in transgender women in Fortaleza, Northeast BrazilOral abstract session with live Q&AD84
TUAC0105 Factors associated with current ART use among transwomen participating in TransAmigas study, São Paulo, BrazilOral abstract session with live Q&AD84
TUAC0201 Continuing low HIV incidence in the expanded pre-exposure prophylaxis (PrEP) implementation in communities - New South Wales study (EPIC-NSW)Oral abstract session with live Q&AC27
TUAC0202 Incidence of HIV-infection with daily or on-demand PrEP with TDF/FTC in Paris area. Update from the ANRS Prevenir StudyOral abstract session with live Q&AC27
TUAC0203 High adherence and sustained impact on HIV-1 incidence: Final results of an open-label extension trial of the dapivirine vaginal ringOral abstract session with live Q&AC28
TUAC0204 What is the effect of layered prevention interventions on HIV risk among adolescent girls in Zambia?Oral abstract session with live Q&AC57
TUAC0205LB Sitakhela Likusasa Impact Evaluation: results of a cluster randomized control trial (cRCT) of financial incentives for HIV prevention among adolescent girls and young women (AGYW) in EswatiniOral abstract session with live Q&AC57
TUAC0301 PrEP adherence and effect of drug level feedback among young African women in HPTN 082Oral abstract session with live Q&AC27
TUAC0302 PrEP uptake and early adherence among at HIV risk transgender women from Rio de Janeiro, Brazil: Results from the PrEParadas studyOral abstract session with live Q&AC55
TUAC0303 Factors associated with stopping HIV pre-exposure prophylaxis (PrEP) for three months or more in the EPIC-NSW trialOral abstract session with live Q&AC27
TUAC0304 PrEP re-initiation after interruption by adolescent girls and young women in Kenya and South AfricaOral abstract session with live Q&AC27
TUAC0305LB Frequent detection of tenofovir-diphosphate among young Kenyan women in a real-world PrEP implementation programOral abstract session with live Q&AC39
TUAC0305LB Frequent detection of tenofovir-diphosphate among young Kenyan women in a real-world PrEP implementation programOral abstract session with live Q&AC39
TUAC0401LB First-in-human trial of MK-8591-eluting implants demonstrates concentrations suitable for HIV prophylaxis for at least one yearOral abstract session with live Q&AC32
TUAC0402LB ASCENT: Phase 2a, randomized, double-blind, placebo controlled study evaluating safety and immunogenicity of two HIV-1 prophylactic vaccine regimens comprising Ad26.Mos4.HIV and either clade C gp140 or bivalent gp140Oral abstract session with live Q&AC30
TUAC0403LB DISCOVER study for HIV pre-exposure prophylaxis (PrEP): F/TAF has a more rapid onset and longer sustained duration of HIV protection compared with F/TDFOral abstract session with live Q&AC27
TUAC0404LB Safety, early continuation and adherence of same day PrEP initiation among MSM and TGW in Brazil, Mexico and Peru: the ImPrEP StudyOral abstract session with live Q&AC27
TUAD0101 How do HIV cure trial researchers respond to an embedded social science study?Oral abstract session with live Q&AD43
TUAD0102 Bringing good participatory practice into action: Considerations and challenges from a sponsor perspectiveOral abstract session with live Q&AD101
TUAD0103 Getting from good participatory practice to good trial outcomes for everyone: How stakeholders believe GPP works (or not)Oral abstract session with live Q&AD56
TUAD0104 The game-changing nature of early and ongoing community engagement in HIV prevention efficacy trials: The AMP studies' experience (HVTN 703/HPTN 081 & HVTN 704/HPTN 085)Oral abstract session with live Q&AD56
TUAD0106 Engaging youth as long-acting HIV prevention product co-researchers in the iPrevent study in Cape Town, South AfricaOral abstract session with live Q&AD56
TUAD0201 Modelling combination interventions including increased school attendance to prevent HIV among girls of school age in South Africa (HPTN 068)Oral abstract session with live Q&AD99
TUAD0202 Improving uptake of prevention of mother-to-child HIV transmission services in Benue State, Nigeria through a church congregation-based approachOral abstract session with live Q&AD6
TUAD0203 Does early infant male circumcision increase mothers' attendance for postnatal care services? Findings from Iringa and Njombe Regions, TanzaniaOral abstract session with live Q&AD94
TUAD0204 Condom and oral PrEP use among female sex workers: Findings from a study in South AfricaOral abstract session with live Q&AD99
TUAD0205 Improving prevention choice while we wait for an HIV vaccine: Prioritizing resources for key population-specific prevention research and implementationOral abstract session with live Q&AD36
TUAD0301 Do changes in development assistance for health crowd out domestic investment for health and what are the implications for HIV/AIDS outcomesOral abstract session with live Q&AD36
TUAD0302 From “nice-to-have” to “necessary”: Increases in domestic financing and perceived value of key population-lead HIV services by the Thai government as international donor funding transitionsOral abstract session with live Q&AD35
TUAD0303 Study comparative NASA and budget tracking: Enabling and empowering the local budget and resource allocation in Bandung districtOral abstract session with live Q&AD40
TUAD0304 Exploring the unit cost variation of Mexico's HIV treatment program: A facility-level longitudinal analysisOral abstract session with live Q&AD48
TUAD0305LB Achieving low antiretroviral (ARV) costs through competitive national tendering and strategic reference pricing: Results from the Republic of South Africa's recently awarded ARV tender (RT71-2019)Oral abstract session with live Q&AD39
WEAA0101 Decreased ex vivo T cell proliferation and increased immune exhaustion in early treated and long-term suppressed HIV-infected pre-adolescents from the CHER trial: Implications for cure strategiesOral abstract session with live Q&AA11
WEAA0102 Immune activation markers and CMV DNA-aemia in children with perinatally acquired HIV infectionOral abstract session with live Q&AA10
WEAA0103 Deep sequence analysis of HIV adaptation following vertical transmission: Importance of human leucocyte antigen-driven selection on the evolution of HIVOral abstract session with live Q&AA8
WEAA0104 No evidence of HIV-1 evolution in circulating reservoirs in children during more than six years of early suppressive antiretroviral therapy despite detectable levels of cell associated-HIV-RNAOral abstract session with live Q&AA1
WEAA0105 Oral TLR7 agonist administration induces an immunostimulatory response in SIV-infected ART-suppressed infant Rhesus macaquesOral abstract session with live Q&AA25
WEAA0201 Longitudinal dynamics of follicular CD4+ T cells in acute SIV infectionOral abstract session with live Q&AA8
WEAA0202 HIV gp120-mediated CD4+T cell activation is inhibited by non-neutralizing gp120-V2 loop antibodiesOral abstract session with live Q&AA10
WEAA0203 Tandem bispecific antibody prevents fully and induces prolonged T cell immunity against pathogenic SHIV in monkey modelsOral abstract session with live Q&AA37
WEAA0204 Bone marrow stromal antigen-2 (bst-2) gene variants associate with HIV-1 control in black South African individualsOral abstract session with live Q&AA27
WEAA0205LB Early ART initiation in acute HIV infection generates long-lived memory HIV-specific CD8+ T cells endowed with efficient proliferative and cytolytic recall responseOral abstract session with live Q&AA8
WEAA0301 Sting agonist as a kick and kill agent to target the HIV reservoirOral abstract session with live Q&AA23
WEAA0302 Different regimens of Romidepsin administration for reversion of SIV latency in a rhesus macaque model of complete virus controlOral abstract session with live Q&AA23
WEAA0303 Fingolimod treatment at ART initiation delays SIV rebound after ART interruptionOral abstract session with live Q&AA24
WEAA0304 Vesatolimod (GS-9620) is safe and pharmacodynamically active in HIV-infected individualsOral abstract session with live Q&AB52
WEAA0305LB Safety and virologic effect of the HIV-1 broadly neutralizing antibodies, VRC01LS or VRC07-523LS, administered to HIV-infected adults in a phase 1 clinical trialOral abstract session with live Q&AA37
WEAB0101 Targeted screening and immediate start of treatment for acute HIV infection decreases time between HIV diagnosis and viral suppression among MSM at a Sexual Health Clinic in AmsterdamOral abstract session with live Q&AB1
WEAB0102 Same-day antiretroviral therapy initiation in Thailand: Different models and initial outcomes from scale-up in five provinces in ThailandOral abstract session with live Q&AB49
WEAB0103 Treatment outcome among patients on ART in Southern Tanzania: Does time of ART initiation matter?Oral abstract session with live Q&AB49
WEAB0104 High acceptability and feasibility of same-day antiretroviral therapy services among HIV-positive adolescents in Bangkok, ThailandOral abstract session with live Q&AB49
WEAB0105 “Test and treat” approaches to HIV care may affect the Xpert MTB/RIF testing impact in high burden TB/HIV settings: Results from a cohort from a rural hospital in Southern MozambiqueOral abstract session with live Q&AB16
WEAB0201 Describing the characteristics and long-term outcomes of adolescents living with perinatally acquired HIV in the IeDEA-Southern Africa Collaboration: 2004-2017Oral abstract session with live Q&AB69
WEAB0202 Predictors of treatment failure, time to switch and reasons for switching to second line antiretroviral therapy in HIV-infected children receiving first line anti-retroviral therapyOral abstract session with live Q&AB67
WEAB0203 Dolutegravir containing regimens may need optimization for African youth failing ARTOral abstract session with live Q&AB12
WEAB0204 Cognitive function among cART-treated children and adolescents with HIV in Zambia: Results from the HIV-associated neurocognitive disorders in Zambia (HANDZ) studyOral abstract session with live Q&AB73
WEAB0205 Response to direct acting antivirals in vertically HIV/HCV co-infected youthsOral abstract session with live Q&AB71
WEAB0301 Improved survival for people living with HIV, with and without tuberculosis, over time in Latin AmericaOral abstract session with live Q&AB16
WEAB0302 Social network characteristics are associated with prevalent tuberculosis infection among people living with and without HIV in nine communities in rural UgandaOral abstract session with live Q&AB16
WEAB0303 HCV reinfection among HIV/HCV co-infected individuals in EuropeOral abstract session with live Q&AB18
WEAB0304 Evaluation of hepatitis C virus rapid diagnostic test in HCV mono- and HCV/HIV co-infected patients from low and middle income countriesOral abstract session with live Q&AB18
WEAB0305 Prevalence, characteristics and outcomes of patients with Cryptococcal meningitis in Maputo, MozambiqueOral abstract session with live Q&AB15
WEAB0306 HPV genotyping is as important as cytology in anal cancer early diagnosisOral abstract session with live Q&AB21
WEAB0401LB Pharmacokinetics of dolutegravir 5mg dispersible tablets in children weighing 6 to < 20kg dosed using WHO weight bandsOral abstract session with live Q&AB64
WEAB0402LB MK-8591 at doses of 0.25 to 2.25 mg QD, in combination with doravirine establishes and maintains viral suppression through 48 weeks in treatment-naïve adults with HIV-1 infectionOral abstract session with live Q&AB38
WEAB0403LB Switching to DTG+3TC fixed dose combination (FDC) is non-inferior to continuing a TAF-based regimen (TBR) in maintaining virologic suppression through 24 weeks (TANGO Study)Oral abstract session with live Q&AB38
WEAB0404LB Durable efficacy of dolutegravir (DTG) plus lamivudine (3TC) in antiretroviral treatment-naïve adults with HIV-1 infection - 96-week results from the GEMINI studiesOral abstract session with live Q&AB49
WEAB0405LB The ADVANCE trial: Phase 3, randomized comparison of TAF/FTC/DTG, TDF/FTC/DTG or TDF/FTC/EFV for first-line treatment of HIV-1 infectionOral abstract session with live Q&AB38
WEAB0406LB ANRS 170 QUATUOR 4/7 days maintenance strategy in antiretroviral treated adults with HIV-1 infection: an open randomised parallel non-inferiority phase III trialOral abstract session with live Q&AB41
WEAC0101 Transmission Linkages among persons with incident HIV-1 infection in North Carolina, 2014-2018Oral abstract session with live Q&AC10
WEAC0102 Applications of HIV genetic networks in Mexico: Implications for preventionOral abstract session with live Q&AC10
WEAC0103 High burden of recent and prevalent HIV infection among men who have sex with men (MSM) in Hanoi, VietnamOral abstract session with live Q&AC3
WEAC0104 Acute HIV infection among individuals who start PrEP: The ImPrEP experience, a demonstration project in the context of combination prevention in Brazil, Mexico and PeruOral abstract session with live Q&AC27
WEAC0105 HIV incidence among men who have sex with men and transgender women in Tijuana, MexicoOral abstract session with live Q&AC3
WEAC0201 Does the use of HIV self-testing kits lead to unintended effects? Evidence from female sex workers in MalawiOral abstract session with live Q&AC33
WEAC0202 Closing the testing gap: High uptake of HIV self-testing among men in rural and peri-urban KwaZulu-Natal, South AfricaOral abstract session with live Q&AC33
WEAC0203 Peer-mobilized HIV self-testing increases case detection and linkage to ART among key populations in BurundiOral abstract session with live Q&AC33
WEAC0204 Community-led HIV self-testing, with and without assistance, successfully reaches key populations and their partners in Viet NamOral abstract session with live Q&AC33
WEAC0205 Social-media based secondary distribution of HIV self-testing among Chinese men who have sex with men: A pilot implementation program assessmentOral abstract session with live Q&AC33
WESY0802LB Qualitative evaluation of PrEP implementation in Brazil - ImPREP stakeholders studyOral abstract session with live Q&AD4
MOPDA0101 Hormonal control of HIV-1 latency by estrogen imparts gender-specific restrictions on the latent reservoirPoster exhibitionA20
MOPDA0102 Cell-associated HIV RNA and the ratio of HIV RNA to DNA have circadian cycles in HIV-positive individuals on antiretoviral therapyPoster exhibitionA20
MOPDA0103 Different HIV transcriptional profiles in memory CD4+ T cells subsets during ARTPoster exhibitionA19
MOPDA0104LB Highly sensitive, limiting dilution-multiplex seminested quantitative PCR-based assay reveals a large active HIV-1 reservoir in infected ART-suppressed individuals and elite suppressorsPoster exhibitionA22
MOPDA0105LB CD8+ lymphocyte mediated suppression of HIV expression in CD4+ T cellsPoster exhibitionA20
MOPDA0106LB The inexorability of latent reservoir formation: HIV induces quiescence in effector CD4+ T cellsPoster exhibitionA19
MOPDB0101 Increased levels of current alcohol use are associated with worse HIV care cascade outcomes among HIV-positive adults in rural Kenya and Uganda in the SEARCH trialPoster exhibitionB36
MOPDB0102 National bio-behavioral surveys suggest improvement in HIV cascade among PWID in UkrainePoster exhibitionB77
MOPDB0103 Crystal methamphetamine and group sex fuel an explosive epidemic of hepatitis C among Thai MSM with HIVPoster exhibitionB18
MOPDB0104 Targeting effective analgesia in clinics for HIV (TEACH): A randomized controlled trial (RCT) to improve satisfaction, confidence, and trust around chronic opioid therapy in HIV carePoster exhibitionB54
MOPDB0105 Prevalence of recent alcohol and substance use in persons with HIV and associations with HIV care cascade outcomes in South AfricaPoster exhibitionB36
MOPDB0106 Hepatitis C and HIV co-infection and related risk determinants among women who inject drugs in the capital city of NepalPoster exhibitionB18
MOPDD0101 Integrating gender-affirming hormone treatment into HIV services facilitates access to HIV testing, syphilis testing, PrEP, and other sexual health services among transgender women in ThailandPoster exhibitionD23
MOPDD0102 Universal test and treat: Reaching underserved farm workers and their families in four sub-districts of uMgungundlovu District, South AfricaPoster exhibitionD17
MOPDD0103 Cervical cancer screening and treatment cascade for HIV positive women in Zimbabwe: Gaps and opportunitiesPoster exhibitionD21
MOPDD0104 Beyond the caregiver: Diffusion of early childhood development knowledge and practices within the social networks of HIV-positive mothers in MalawiPoster exhibitionD24
MOPDD0105 Feasibility and outcomes of integrating diabetes screening into routine viral load monitoring among patients on antiretroviral therapy in MalawiPoster exhibitionD21
MOPDD0106LB Tuberculosis preventive therapy in select PEPFAR supported countriesPoster exhibitionD20
MOPDD0201 Sexual health education in a digital savvy adolescent generation: Efficacy of gamified learning in a low-tech settingPoster exhibitionD100
MOPDD0202 Managing stock levels of HIV commodities using electronic systems in Baylor Uganda, Rwenzori regionPoster exhibitionD19
MOPDD0203 Empowering with PrEP (ePrEP) - a peer-delivered online social network intervention for PrEP adoption among young Black and Latinx men who have sex with men: Cluster randomized controlled trialPoster exhibitionD19
MOPDD0204 Effectiveness of HIV Telehealth Training Program in increasing the level of knowledge of HIV care personnel in the Philippines: A pilot studyPoster exhibitionD42
MOPDD0206 #endHIVbg: An innovative, targeted national campaign to engage hard-to-reach at-risk MSM and transgender people with a confidential rapid oral home HIV test, in partnership with GrindrTMPoster exhibitionD81
MOPDD0207 Achieving 96% ARV collection compliance through innovative ATM technologyPoster exhibitionD14
TUPDA0101 Maternal HIV infection alters the community composition and dynamics of the enteric microbiome of associated infantsPoster exhibitionA12
TUPDA0102 Glycomic determinants of gut microbial dysbiosis and translocation during suppressed HIV infectionPoster exhibitionA12
TUPDA0103 Relevance of Reg3α and I-FABP on microbial translocation, inflammation and reservoir size in people living with HIVPoster exhibitionA12
TUPDA0104 HIV acquisition risk and genital inflammation associated with hormonal contraceptives is dependent on the vaginal microbiomePoster exhibitionA30
TUPDA0105 Recent injectable contraception correlates with reduced cervicovaginal mucosal growth factor expression in South African womenPoster exhibitionA9
TUPDA0106 The effect of hepatitis C (HCV) cure on markers of macrophage activation and microbial translocation among HIV seropositive womenPoster exhibitionB18
TUPDA0107LB Contraceptive-induced changes in genital tract HIV-1 cellular targets and microbiota among women enrolled in the ECHO TrialPoster exhibitionA30
TUPDB0101 Apples and oranges: Assessment of the care cascade in sub-Saharan AfricaPoster exhibitionB11
TUPDB0102 Gaps in the continuum of care. Loss to follow-up and return to care: Who is at risk?Poster exhibitionB46
TUPDB0103 Understanding gaps in the HIV treatment cascade in 11 West African countries: Findings from the regional Community Treatment ObservatoryPoster exhibitionB11
TUPDB0104 The “Failure Cascade” for patients with unsuppressed viral load in Zambia: Results from a large HIV treatment cohortPoster exhibitionB46
TUPDB0105 The hepatitis C treatment cascade in the era of direct-acting antivirals (DAAs), and barriers to DAA treatment initiation, among US men and women with and without HIVPoster exhibitionB18
TUPDB0106 Actively contributing to a cascade of change: Analysis of the TB treatment cascade among children and adolescents living with HIV in six high TB/HIV burden countriesPoster exhibitionB70
TUPDC0101 Measuring perceptions of sexual risk among adolescent girls and young women taking PrEP: A new qualitative method using visual timelines in HPTN 082Poster exhibitionD54
TUPDC0102 High uptake and adherence to periconception PrEP among women in South AfricaPoster exhibitionC42
TUPDC0103 Safer conception services: A model to support progress towards 90-90-90 goals for men and women with horizontal and vertical HIV transmission risksPoster exhibitionC42
TUPDC0104 Prevalence of HIV and other sexually transmitted infections among female sex workers in Moscow, Russia: Results from a community-based, cross-sectional study using respondent driven sampling methodologyPoster exhibitionC6
TUPDC0105 PrEP use and sexually transmitted infections are not associated longitudinally in a cohort study of young men who have sex with men in ChicagoPoster exhibitionC27
TUPDC0106 Prospective, multicenter study to assess point prevalence, incidence and recurrence of sexually transmitted infections in men who have sex with men in Germany: BRAHMS studyPoster exhibitionC35
TUPDD0101 Measuring anticipated sex-work stigma: Scale validation and association with HIV and non-HIV service utilizationPoster exhibitionD83
TUPDD0102 Mapping key population hotspots in Nigeria for targeted HIV program planningPoster exhibitionD4
TUPDD0103 The M-Spot 2 Study: Feasibility of measuring viral load longitudinally using home-collected dried blood spot specimens of high-risk MSM living with HIVPoster exhibitionD9
TUPDD0104 Developing and validating a model for risk-based differentiation of HIV prevention and testing services for female sex workers: Experiences from Maharashtra, IndiaPoster exhibitionD98
TUPDD0105 Receipt of medication-assisted treatment halves the risk of HIV-1 RNA viral load rebound for HIV-positive women who use illicit drugsPoster exhibitionD82
TUPDD0106 Police harassment and alcohol and drug abuse is associated with poorer 6-month retention among transgender women starting ART in a clinical trial in ArgentinaPoster exhibitionD84
TUPDD0201 Exploring the mediating role of tobacco use in the relationship between intersectional stigma and HIV clinical outcomes among women living with HIV in CanadaPoster exhibitionD70
TUPDD0202 Implementation of social capital theory and process to strengthen state-level combination prevention outcomes in 12 states in MexicoPoster exhibitionD51
TUPDD0203 Frustrated patients, frustrated providers: A comprehensive integrated conceptual model to explain why patients delay, decline, or discontinue HIV medication and strategies to boost sustained HIV viral suppression in populations at-riskPoster exhibitionD53
TUPDD0204 Estimating plausible ranges on the scale of implementation for evidence-based HIV/AIDS interventions in the USPoster exhibitionD48
TUPDD0205 Extrapolation of population size estimates for key populations: Impact of method of extrapolation on estimates produced using regional estimates of female sex workers from Tanzania as an illustrative examplePoster exhibitionD1
TUPDD0206LB Quantifying the contribution of different aged men and women to onwards transmission of HIV-1 in generalised epidemics in sub-Saharan Africa: A modelling and phylogenetics approach from the HPTN071 (PopART) trialPoster exhibitionD53
WEPDB0101 Evolution of HIV drug resistance surveillance in Brazil: A declining trend to celebratePoster exhibitionB44
WEPDB0102 Thresholds of pre-treatment HIV-1 drug resistance indicate regions for priority actions in the antiretroviral therapy program of CameroonPoster exhibitionB44
WEPDB0103 Prevalence and predictors of etravirine resistance mutations in HIV-positive individuals failing second-line antiretroviral therapy in UgandaPoster exhibitionB44
WEPDB0104 HIV-1 drug resistance and third-line outcomes among children and adolescents failing second-line therapy in MalawiPoster exhibitionB67
WEPDB0105 HIV-1 drug resistance surveillance among parturient women on anti-retroviral therapy in the Eastern Cape, South Africa: Implications for elimination of mother-to-child transmissionPoster exhibitionB44
WEPDB0106 Going beyond guidelines: HIV-1 drug resistance testing at low-level viremia, a South African experiencePoster exhibitionB12
WEPDC0101 #HIVSelfTest: A social media campaign to promote HIV self-testing among young people in NigeriaPoster exhibitionC44
WEPDC0102 Developing a novel mobile app to support HIV testing and PrEP uptake among young MSM: The LYNX StudyPoster exhibitionC36
WEPDC0103 Stigma and online sex-seeking among men who have sex with men and transgender women in Tijuana, MexicoPoster exhibitionC36
WEPDC0104 Transgender-led social media interventions effectively identify transgender woman subpopulations with substantial risk of HIV acquisition and successfully link to HIV prevention, care and treatment servicesPoster exhibitionC44
WEPDC0106 Pilot study of a gamified, social networking app shows improvements in PrEP adherence among YMSM in the USPoster exhibitionC46
WEPDC0107 Digitizing interventions: An internet-based approach to reach out to the 'hidden network of men who have sex with men' in Mumbai, IndiaPoster exhibitionC44
WEPDC0201 Healthcare providers' attitudes and experiences delivering oral PrEP to adolescent girls and young women: Implementation research to inform PrEP rollout in Kenya, South Africa, and ZimbabwePoster exhibitionC27
WEPDC0202 Providers' attitudes towards and experiences with oral pre-exposure prophylaxis (PrEP) implementation in the SEARCH trial in Kenya and UgandaPoster exhibitionC27
WEPDC0203 Implementation challenges and strategies in integration of PrEP into maternal and child health and family planning services: Experiences of frontline healthcare workers in KenyaPoster exhibitionD1
WEPDC0204 Surmounting PrEP delivery challenges through adaptation of implementation guidelines: Lessons learned from HIV care clinics in KenyaPoster exhibitionC27
WEPDC0205 Training, communication, and prescribing patterns of pre-exposure prophylaxis (PrEP) among a sample of nurse practitioners in the United States: Important gaps and opportunitiesPoster exhibitionD5
WEPDC0206 Attitudes, confidence and knowledge towards antiretroviral pre-exposure prophylaxis (PrEP) prescription among healthcare providers in ThailandPoster exhibitionC27
PUB001 National trends in TB/HIV comorbidity in Ukraine, 2008-2017Publication OnlyB16
PUB002 Scaling up peer driven intervention plus: An innovative approach to reach hidden MSM and TG in CambodiaPublication OnlyC47
PUB003 Use of WhatsApp technology as a platform for improving Timeliness of data reporting in a hard-to-reach Rural Riverine Health facilities in South-South NigeriaPublication OnlyD42
PUB004 Potential impact of implementing index partner notification to reach undiagnosed people living with HIV in RwandaPublication OnlyD12
PUB005 Provider-initiated HIV testing finds the majority of HIV positive persons in KenyaPublication OnlyC36